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i. ABSTRACT 
The mouse small intestine possesses a highly complex structure with finger-like protrusions 
– villi – surrounded by invaginations called the crypts of Lieberkühn. Until it reaches its mature 
form, the embryonic small intestine undergoes a series of morphological and molecular 
changes. However, little is known about the molecular program involved in the development 
and establishment of the mouse small intestine. 
Id2, an inhibitor of DNA binding and differentiation, has been found to play a role in several 
biological processes, such as stem cell maintenance and tumorigenesis, and is a plausible 
candidate to be involved in the mechanisms mentioned above.  
The present study investigated the possible Id2 role in the development of the mouse small 
intestine through the ablation of the Id2+ cell population via Diphtheria Toxin (DT). The work 
conducted aimed to establish a DT-sensitive cell system for the ablation of the Id2+ cell 
population in the mouse embryonic small intestine, and compare the genetic profiles between 
sorted Id2+ epithelial iDTR- and iDTR+ cell populations. It was also proposed to evaluate the 
contribution of Id2 in the emmergence of the Lgr5+ cell population. 
 
Upon treatment of the embryos with DT, apoptosis was detected by immunohistochemistry 
targeting γH2AX in the iDTR+ embryos, with changes in the morphology of the iDTR+ 
embryonic small intestine also being showed by hematoxylin and eosin staining. Furthermore, 
upon cell sorting, Id2+ cells were found to be reduced when compared to control.  
Gene expression of the sorted cells by qPCR also showed a decrease in Id2 levels. Analysis 
of the high-red iDTR+ cell population by qPCR of a panel of genes – Lgr5, PUMA, Ascl2, Wnt6, 
Wnt11, Sfrp5, Rspo1, Rspo3, Snai2, Smoc2, Id1, Id3, Kcnq1, Kcne3, TBP, St8sia3, Slc2a3, 
OneCut2 – suggests that this cell population acquires proliferative and stem cell characteristics. 
The analysis of the non-red iDTR+ cells genetic profile also suggests a proliferative character.  
 
Key words: Embryonic small intestine, cell ablation, Diphtheria Toxin, Id2+.
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ii. RESUMO 
O intestino delgado de ratinho possui uma estrutura altamente complexa, apresentando 
protrusões – as vilosidades – rodeadas por invaginações, designadas criptas de Lieberkühn. O 
intestino delgado embrionário passa por uma série de alterações morfológicas e moleculares até 
atingir o seu estado maturo. No entanto, pouco se sabe acerca dos programas moleculares 
envolvidos no desenvolvimento e a maturação do intestino delgado de ratinho. 
O gene Id2, um inibidor de ligação do DNA e de diferenciação, é descrito como possuindo 
um papel relevante em vários processos biológicos, nomeadamente na manutenção de células 
estaminais e a tumorigénese, sendo então um possível candidato a estar envolvido nos 
mecanismos mencionados anteriormente.  
O trabalho apresentado investigou o possível envolvimento de Id2 no desenvolvimento do 
intestino delgado de ratinho, através da ablação da população celular Id2+ mediada pela 
Diphtheria Toxin (DT). Este projeto teve como objetivo estabelecer um sistema de células 
sensíveis à ação da DT para proceder à ablação da população celular Id2+ no intestino delgado 
embrionário de ratinho, bem como comparar os perfis genéticos entre células epiteliais iDTR- 
e iDTR+ isoladas. Outro dos objetivos propostos foi avaliar a contribuição de Id2 no 
aparecimento da população celular Lgr5+. 
 
Após o tratamento dos embriões com a DT, foi detetada apoptose nos embriões iDTR+, 
através de ensaios de imunohistoquímica, tendo como alvo γH2AX, bem como alterações na 
morfologia destes embriões, detetada por staining com hematoxilina e eosina. Além disso, 
detetou-se uma redução na população Id2+ em embriões iDTR+, comparativamente às 
condições controlo.  
Através de análise por qPCR, as células isoladas apresentaram um decréscimo da expressão 
de Id2. A população de células Id2+ high-red foi analisada geneticamente para o seguinte 
conjunto de genes – Lgr5, PUMA, Ascl2, Wnt6, Wnt11, Sfrp5, Rspo1, Rspo3, Snai2, Smoc2, 
Id1, Id3, Kcnq1, Kcne3, TBP, St8sia3, Slc2a3, OneCut2 –, e os resultados sugerem que esta 
população celular adquire características proliferativas e de células estaminais. A análise do 
perfil genético de células Id2+ non-red sugere igualmente um perfil proliferativo. 
 
Palavras-chave: Intestino delgado embrionário, ablação celular, Diphtheria Toxin, Id2+.
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1. INTRODUCTION 
1.1. Small intestine 
The small intestine is a highly organized organ that, among other functions, serves mainly 
for absorptive and immunological purposes1,2. In mammals, the small intestine is the most 
proliferative and self-renewing structure and its epithelium is renovated every 4 to 5 days3,4,5. 
Starting in gastrulation and endoderm specification, this complex tissue undergoes a series 
of changes until it reaches its final form after the birth2.  
 
1.1.1. Adult small intestine 
The adult intestinal tract can be described as a tube composed of three different layers 
– mucosa, submucosa and muscularis mucosa (Figure 1.1). Together, the epithelium, the 
lamina propria and the muscular mucosa constitute the mucosa – structurally and functionally, 
the intestine’s most complex layer -, which  is supported by the submucosa, a layer of 
connective tissue6,7. The submucosa is rich in inflammatory cells, nerve fibres, arteries and 
small venous channels, while the muscularis mucosa, in association with the enteric nervous 
system8, is responsible for the intestine’s peristaltic movements6.   
 
 
 
Figure 1. 1. Structure of the adult small intestine in mammals. The tubular small intestine is formed by 3 main 
layers of different tissues – the mucosa, the submucosa and the muscularis mucosa. These structures are oriented 
circumferentially around the lumen. In the mucosa, and facing the lumen, are the villi – responsible for making 
the small intestine the biggest surface in the body. Mouse image by ©Laurie O’Keefe (2007)9. 
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The lumen, the innermost layer of the small intestine, consists of a tubular structure, 
in which the digested nutrients pass through, and has a very distinct morphology. It possesses 
finger-like protrusions, the villi8 - due to which intestine’s surface area is dramatically 
enlarged1,10 -, surrounded by multiple invaginations called crypts of Lieberkühn8 (Figure 1.1). 
Together with its characteristic morphology, the cells that populate the lumen is what allows 
the intestinal epithelium to carry out its function. 
 
As the intestinal epithelial cells surround all the lumen, there are three main types of 
cells covering the villi  – enterocytes, Goblet cells and enteroendocrine cells1,11 (Figure 1.2). 
While the first carries out absorptive functions, the remaining are classified as secretory cells2,12.  
 
  
 
Figure 1. 2. Differentiated cells in the small intestine's epithelium. Absorptive cells are polarized and have a 
basal nucleus while enteroendocrine cells have neurosecretory granules.  A prominent feature of Goblet and Paneth 
cells is their secretory granules13 (shown in green). Image adapted from Crosnier et al. (2006)12. 
 
Enterocytes constitute more than 80% of the epithelial cells, but are mainly present at 
the proximal end of the small intestine. Absorptive cells, although mainly responsible for the 
absorption and transport of nutrients across the epithelium, also release hydrolytic enzymes1,8. 
These cells have a columnar shape, a basal nucleus and possess apical microvilli (as shown in 
Figure 1.2), increasing their absorptive surface13. Goblet cells secret mucus and are found 
mainly at the distal end of the small intestine and in colon, where they are more needed given 
their lubricating role8. These cells are characterized by mucigen granules in their cytoplasm that 
will secrete mucins and other proteins. The granule contents are important for the movement 
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and expulsion of gut contents, as well for providing protection against shear stress and chemical 
damage1. Lastly, enteroendocrine cells, as the name suggests, are responsible for hormonal 
release and constitute a minor cell population (around 1%)1,8,11. These cells are distributed along 
the intestinal mucosa as intestinal cells and the hormones they secrete, such as serotonin,  play 
an important role in the control of the gut physiological conditions1,8,14. 
Another secretory cell type found in the intestinal epithelium are Paneth cells. These 
cells are rich in cytoplasmic granules that, once secreted, release substances vital to the 
maintenance of the intestine’s physiology. Among these are lysozymes, antimicrobials and 
defensins, which emphasises the role of Paneth cells in innate immunity and host-microbe 
interactions1,8,15. Paneth cells differ from the other differentiated cells mentioned above due to 
having a higher life span – they last up to 6 weeks while the others survive for only 4 or 5 
days16,15 –, and for being found at the base of the Lieberkühn crypts1,8. 
 
Due to the harsh conditions the intestinal epithelium is continuously exposed to, there 
is a need for a rapid self-renewal of the epithelial cells. This process is coordinated by the 
proliferative compartment found in the Lieberkühn crypts. Here, besides Paneth cells, two cell 
populations can be found – intestinal stem cells (ISC) and transit amplifying (TA) cells7,16 –, 
the latter giving rise to 250 new epithelial cells per day17,18. These new epithelial cells migrate 
upwards – from the bottom of the crypt until the top of the villus – and undergo differentiation 
until they reach the crypt-villus junction17,18. At this point, the completely differentiated cells 
continue to travel upward the villi. In order to keep the balance in the number of epithelial cells, 
the older cells undergo apoptosis and are exfoliated at the tip of the villus, as the newly 
differentiated cells migrate from the crypt to substitute them. The exception are the Paneth cells, 
that migrate downwards and establish themselves at the bottom of the crypts1,8, 13,15,16. 
 
The position of each cell type along the crypt-villus axis is portrayed in Figure 1.3. 
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Figure 1. 3. Localization of the different cell populations in the crypt-villus axis of mouse small intestine 
epithelium. The crypt-villus axis is divided into two compartments: a proliferative and monoclonal one, 
maintained by stem cells – the crypts –, and a differentiated and polyclonal one – the villus13. Image from Sancho 
et al. (2015)19. 
  
 Until it reaches the morphological structure presented in Figure 1.3, the small intestine 
undergoes a series of changes along its differentiation process from the embryonic endoderm2.
   
1.1.2. Small intestine in embryos 
Once all the germ layers – endoderm, mesoderm and ectoderm – are established in the 
early vertebrate embryo, the primitive gut tube is formed as a consequence of the series of 
morphogenic changes occurring in the endoderm2,20,21. 
The formation of primitive gut starts with the endoderm closure at the anterior and 
posterior intestinal portals, progressing towards the middle of the embryo where they will meet 
and form a closed tube around embryonic day (E) 8.0 and E9.02,20,22 (Figure 1.4). As the gut 
tube forms, the epithelium undergoes a patterning process along the anterior-posterior axis that 
gives rise to the foregut at the anterior region, and to the midgut and hindgut at the posterior 
region of the tube7,20. The foregut will give rise to esophagus, lungs, thyroid, liver, pancreas 
and stomach, while the midgut and hindgut will differentiate into the small and large intestine, 
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respectively2,20. At E9.5, the simple epithelium condenses into a pseudostratified epithelium 
and, from this stage until E13.5, as the tube lengthens to the size of the embryo, the mesenchyme 
and the lumen also increase their size20,21,23. 
 
 
Figure 1. 4. Schematic representation of embryonic intestinal development in mouse. (A) From E8.0 to E9.5, 
the primitive gut tube is formed. At E10.5, the epithelial endoderm is pseudostratified (B) and after morphological 
changes occurred will give rise to a stratified epithelium (C). (D) Villi begin to emerge around E15.0 and are fully 
developed by E16.5. (E) By E18.5, the intestine has its adult morphology and the proliferative cells (green) only 
exist at the bottom of the crypts (F). Image adapted from Spence et al. (2011)2.  
 
With the gut tube formed, the epithelium is reorganized at E14.5. The pseudostratified 
epithelium undergoes morphologic changes – it changes from a tightly packed simple 
epithelium with nuclei at several levels to a stratified one with nuclei at the basal level2,21. At 
the same developmental day (E14.5), villi start to form due to the invagination of mesenchyme 
into the epithelium7. Both processes – villus emergence and epithelial restructuring take place 
in a proximal-to-distal manner20,21.  
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As the villi emerges, proliferation increases at the base of the villi and becomes 
progressively less abundant on the villus epithelium2,7,21. By E17.0, proliferating cells become 
confined to the crypts of Lieberkühn2,21. Stem cells are also present in the intervillus region and, 
together with the proliferative cells, they will be responsible for the maintenance of the adult 
small intestine21. 
 
1.2. Stem cells 
 In the small intestine, homeostasis is maintained through the activity of a minor population 
of long-lived resident stem cells 4,5,8,24, together with  the balance between stem cell 
proliferation and renewal with differentiation25. 
In general, stem cells (SC) are present in an organism through the embryonic stage and 
adult life and are characterized by two major properties – their self-renewal capacity and the 
ability to generate all the cell types of the organ where they reside26.  
During the embryonic development, cells of the inner cell mass of the blastocyst will give 
rise to all the three germ layers – endoderm, ectoderm and mesoderm. Embryonic stem cells 
(ESC) can be derived from the inner cell mass and retain the capacity to differentiate into all 
cells of the adult organism, i.e. they are pluripotent. On the other hand, adult stem cells are 
multipotent, since they can only self-renew and differentiate into the different cells of the 
specific tissue from which they were isolated16. 
 
1.2.1. Stem cells in adult small intestine 
As mentioned in section 1.1.1, there are two cell populations in the intestine’s crypt – 
ISC and TA cells –, which, together with Paneth cells, are responsible for the renewal of the 
intestinal epithelium, thus keeping homeostasis. ISC are confined to the bottom of the crypts 
(Figure 1.5) – where approximately six individual cells are present –, and are responsible to 
fuel the cells for epithelial renewal and are the only source of cells for the renewal of the 
epithelium, so its population should be kept constant1,13.  
 
Currently, there are two models that hypothesise how the ISC population is maintained 
– the Deterministic and the Stochastic model. The Deterministic model states that individual 
stem cells divide asymmetrically, i.e., they give rise to one stem cell, that will be kept at the 
bottom of the crypt, while the other cell will become a TA cell and migrate to the proliferative 
zone, where  it will undergo proliferation cycles every 12-16 h7,13. While this model describes 
few stem cells at the niche, the Stochastic model, on the other hand, suggests that many stem 
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cells reside at the bottom of the crypt and that, as they divide symmetrically, stem cells produce 
either two stem cells (meaning no TA cells), one stem cell and one TA cell or two TA cells 
(meaning no daughter stem cell), which leads to an unbalance between the descendants of each 
stem cell lineage over time13,27. The Stochastic Model is also known as Niche model, as it 
suggests the existence of an environment at the bottom of the crypt – termed niche – that 
determines the “stemness” of the cells through the action of intracellular factors13. 
 
 
 
Figure 1. 5. Stem cells of the small intestine. There are two stem cell populations reported in the literature - +4 
cells and Crypt Base Columnar (CBC) cells. The genetic markers of each population are also portrayed. Image 
adapted from Sancho et al. (2015)19. 
  
Two stem cell populations exist in the small intestine (Figure 1.5) – Crypt Base 
Columnar (CBC) cells and +4 label retaining cells (LRC) –, but their specific location within 
the crypt is not well known. It has been proposed that either they are located just above Paneth 
cells or within the fourth and fifth cells from the bottom of the crypt28.  Currently, there are two 
models that describe these stem cell populations – the Classic model and the Stem Cell Zone 
model. The first one is based on the findings of Cairns et al. (1975) and Potten et al. (1974) and 
the second one in the work developed by Cheng and Leblond (1974)29. 
 
In 1974, Cheng and Leblond proposed that a small population of undifferentiated 
elongated cells located amongst Paneth cells and near the base of crypt were the cells from 
which all the differentiated cell types in the intestine would derive from30. This conclusion came 
after they discovered that crypts were not populated only by Paneth cell but also by actively 
dividing columnar cells, while doing electronic microscopy studies31,32.  These cells - slender, 
immature and cycling – were called CBC cells and it was also found that they are sensitive to 
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tritiated thymidine ([3H]dT) exposure30,31. The authors also reported that the surviving CBC 
cells would phagocyte surrounding damaged cells after [3H]dT exposure. These radioactive 
phagosomes were initially present only in occasional CBC cells, but were latter detected within 
differentiated cells belonging to the four cell lineages in the intestine18,30,31,33. These findings 
were interpreted as a proof of CBC cell’s stemness. 
Moreover, the CBC stem cell model suggests that these stem cells have a division cycle 
of 24h and that their progeny moves to cell position 4-5, where they continue to divide with a 
daily cycle30. 
 
On the other hand, the Classic Model, proposed by Potten in 1974, states that stem 
cells reside at position +4 relative to the crypt bottom, immediately above of the highest Paneth 
cell in the small intestine1,4,30,34, as shown in Figure 1.5. After cell tracking experiments, these 
authors reported that the cells at +4 position were sensitive to X and γ radiation and had labelling 
retaining properties - both desirable stem cell characteristics. Sensibility to radiation would 
prevent genetic abnormalities from being passed on to the progeny cells and the long-term DNA 
label retention is a result of the asymmetrical segregation of DNA, meaning that while the 
template DNA strands are retained in the +4 stem cells, the daughter cells inherit a newly 
synthetized strand8,30,18,35. Also called LRC, +4 cells also have an active proliferative cycle of 
24 h, like CBC35.  
To note that studies conducted by Potten at the time failed to show that +4 cells can 
give rise to all the differentiated lineages in the intestinal crypt36. Also, this model is still to 
validate since 1) some proposed stem cell markers for this population are poorly characterized 
and 2) some of the already validated ones seem to mark epithelial cell populations with cellular 
features distinct from the LRC population described by Potten37. 
 
1.2.2. Stem cell markers 
Although the localization of the stem cell populations in the intestine is relatively 
known, their identification and isolation is still a challenge. In order to overcome this, the 
identification of valid ISC markers is of key importance. 
The list of potential ISC markers includes Lgr5, Bmi-1, Mushashi-1, m-Tert, Ascl2, 
Sox9 and OLFM4, among others8,19,30,31,38. However, with exception of Lgr5 and Bmi-1, none 
of the other markers have yet been related with cells capable of multi-lineage differentiation30. 
Therefore, only Lgr5 and Bmi-1 will be discussed. 
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Barker et al. (2007) reported Lgr5 (Leucine-rich-repeat-containing G-protein-coupled 
receptor 5), also known as Gpr49 (G-protein coupled receptor 49), as a marker for CBC cells. 
Lgr5 is a 7 transmembrane protein that acts as a receptor for antagonists of the Wnt pathway – 
the R-spondins – and also marks proliferative cells in several other adult tissues4,35,38. In their 
study, the authors showed that this marker is expressed at the bottom of the intestinal crypts of 
adult mice and that Lgr5+ cells gave rise to long-lived clones containing all intestinal cell types. 
With these findings, Lgr5 was then considered the most reliable ISC marker39,40. 
On the other hand, Bmi-1 (B cell specific Moloney murine leukemia virus integration 
site 1) is a polycomb group protein and belongs to a group of transcriptional repressors that 
controls the development by the regulating of cell growth and differentiation genes28,30,41. The 
work of Sangiorgi and Capecci (2008) suggested Bmi-1 as a possible marker for +4 cells by 
showing that this gene consistently marks long-lived cell clones and that the ablation of the 
Bmi-1 cell population eliminates the epithelium of whole crypt units. Also, the location of Bmi-
1 single cells was reported to be above Paneth cells, in positions +4 and +5 from the base of the 
crypt28,40. 
 
With two possible ISC populations, two questions arise: 1) Could Lgr5+ and Bmi-1+ 
cells be the same population? and 2) Which one corresponds to the genuine stem cell 
population?  
Tian et al. (2011) and Yan et al. (2012) have reported that these markers identify two 
distinct populations. The first author’s data suggest that Bmi-1+ cells are located upstream of 
Lgr5+ stem cells and contribute to the replenishment of the pool of active stem cells. Also, when 
the cells that express Lgr5 are eliminated, the number of Bmi-1+ cells increases - probably to 
compensate the loss – and, in this conditions, contributes to the generation of all cell types in 
the intestine until the Lgr5 population has recovered42. Moreover, Yan and colleagues showed 
that these two stem cell populations are functionally distinct: while Lgr5+ cells have a greater 
contribution on maintaining the small intestine’s homeostasis, Bmi-1+ cells are quiescent, 
radioresistant and, upon injury, they rapidly proliferate in order for the epithelium to 
regenerate4,43. Together, these findings support a model where different ISC populations have 
separate but cooperative roles within the small intestine.  
Lineage tracing experiments conducted by Barker et al. (2007) in Lgr5-EGFP-IRES-
creERT2-LacZ mice, in which LacZ expression was induced by tamoxifen (TAM), showed that 
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the number of cells expressing LacZ would increase as more days passed by since the induction. 
This supported the Lgr5+ cells capability to maintain the epithelium’s self-renewing state. It 
was also reported the existence of epithelial cells, such as Paneth and Goblet cells, amongst the 
LacZ-stained clones39. According to these authors and their findings, Lgr5+ CBC cells are the 
genuine intestinal stem cell population. 
 
1.2.3. Stem cell niche 
The stem cell niche hypothesis was proposed in 1978 by Schofield, who described the 
“niche” as a microenvironment of cells contributing to the stem cell behaviour and allows them 
to maintain tissue homeostasis. According to this author, the SC niche is characterized by the 
following properties: it provides an anatomic place to regulate stem cell number, instructs stem 
cells to self-renew or commit to differentiation and influences their motility13,18,44,45,46 (Figure 
1.6). 
 
 
Figure 1. 6. Composition of the SC niche. Several molecular stimuli and cellular components take part in the 
maintenance of the SC niche – a complex and heterotypic dynamic 
structure<sup>47</sup><sup>47</sup><sup>47</sup>. Image from Lane et al. (2014)47. 
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Surrounding the Lieberkühn crypts, where ISC reside together with +4 cells and 
Paneth cells, the niche is composed by different cell types, such as myofibroblast, endothelial 
and neural cells, immune cells and smooth muscle cells18,45, among other components (Figure 
1.7).  
 
 
Figure 1. 7. Representation of the ISC niche. In the small intestine, Paneth cells support ISC through the 
segregation of Wnt3, epidermal growth factors (EGF) and Notch. Other cells types surrounding the stem cells also 
play a role in the maintenance of the niche. Image adapted from Lane et al. (2014)47. 
 
Paneth cells are thought to be a key component of the ISC niche, given the proximity 
with CBC stem cells18 (Figure 1.7). Several genetic ablation and knockout studies confirmed 
these findings, such as the work of Sato et al. (2011). After the ablation of the majority of 
Paneth cells, these authors reported a reduction in the CBC population and also a proportional 
reduction in the same stem cell pool when partial ablation of Paneth cells was achieved. The 
remaining stem cells were always found contiguously to the remaining Paneth cells48. However, 
studies also showed that Paneth cells are only essential for the small intestine’s homeostasis in 
vitro but not in vivo. This is supported by the studies of Kim et al. (2012), where CBC cells 
maintained their normal function when Paneth cells were completely ablated. Durand et al. 
(2012) confirmed these findings but also reported that Math1-deficient crypts required 
exogenous Wnt when grown in organoid culture. Together, this results point to a redundancy 
between Paneth cell and the stromal environment that surrounds the epithelium18. 
Located beneath the intestinal crypts, stromal cells and myofibroblast support ISC 
during morphogenesis, differentiation and proliferation. Studies showed that these cells express 
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endogenous R-spondin 3 (Rspo3) – a Wnt agonist – supporting the formation of the intestinal 
epithelium through the Wnt signalling pathway45.   
 
Another key regulator of the intestinal epithelial growth are neural cells, namely the 
enteric neurons. These neurons express the glucagon-like peptide (GLP)-2 receptor. GLP-2 
production by a subset of enteroendocrine cells – the L cells – stimulates the proliferation of 
enterocytes45,49. The L cells can also function as a nutrient sensor49. 
Moreover, mesenchymal cells expressing Foxl1 are also reported to play a role in the 
niche. Aoki et al. (2011) showed that these cells express high levels of Rspo3 and fibroblast 
growth factor 2, as well as antagonists of the Bone Morphogenetic Protein (BMP) pathway. 
Through the ablation of Foxl1-expressing mesenchymal cells, authors reported epithelium 
disruption, an effect in the stem cell population by the reduction of expression of the stem cell 
marker Olfm4 and a reduction in Wnt signalling50. 
 
The maintenance of the proliferative character in the crypt, where ISC are located, and 
the different cell fates along the crypt-villi axis are regulated by several signalling pathways. 
 
1.3. Cell differentiation and proliferation in the small intestine 
The intestinal homeostasis, maintained by the balance between cell proliferation and 
differentiation, is assured by a complex network of signalling pathways, such as Wnt, BMP, 
Notch, Hedgehog (Hh) and Eph/Ephrin (Figure 1.8). 
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Figure 1. 8. Signalling pathways involved in the maintenance of intestinal homeostasis and their gradients 
of expression along the crypt-villi axis. Image adapted from Krausova and Korinek (2014)5. 
 
1.3.1. Wnt/β-catenin pathway 
The Wnt signalling pathway is the main responsible for the proliferation of the small 
intestine’s epithelium, and also plays a role in processes such as cell differentiation and 
migration, among others1,5,51,52,53. This signalling is ensured by 19 secreted glycoproteins of 
the Wnt family and its receptors – the Frizzled (Fzd) protein family, which comprises 10 
members in human and mouse. The Wnt family is highly conserved through the animal 
kingdom and all the proteins, generally with 45 kilodalton (kDa), share conserved features 
essential for their function1,30,51,52,54,55.   
  
There are two major branches of the Wnt pathway – the canonical and the non-
canonical -, being the first dependent of β-catenin, while the second is not52. 
The canonical Wnt pathway (Figure 1.9) activation occurs when a Wnt ligand binds 
to the complex formed by the seven-transmembrane Fzd receptor and its co-receptor LDL-
related receptor protein (LRP) 5/652,55,56,57,58. In the absence of pathway activation, β-catenin 
in the cytoplasm is captured by a destruction complex formed by Axin, Adenomatous 
Polyposis Coli (APC), Casein Kinase 1 (CK1) and Glycogen Synthase Kinase 3β (GSK3β).  
CK1 and GSK3β will target β-catenin for ubiquitination and proteasomal degradation through 
the phosphorylation of its N-terminus, thus preventing the transcription of Wnt target genes. 
When Wnt binds to its receptors, the intracellular part of LRP is phosphorylated by CK1γ as a 
consequence of the phosphorylation of Disheveled (Dsh) proteins. Axin is then recruited by 
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this complex and the degradation of β-catenin is avoided, leading to the accumulation of this 
protein in the cytoplasm. Upon translocation to the nucleus, β-catenin will displace Groucho 
proteins, transcriptional repressors, and interact with T-cell factor/Lymphoid Enhancer Factor 
(TCF/LEF), thus inducing the expression of Wnt target genes55,57,58,59. 
 
 
Figure 1. 9. Schematic representation of the canonical Wnt/β-catenin pathway. In the absence of the Wnt 
ligands Fzd and LRP5/6, β-catenin is degraded and the Wnt target genes are not expressed (a). When the canonical 
pathway is activated,  β-catenin acumulates in the cytoplasm and, once in the nucleus, it binds to TCF/LEF to 
promote the expression of Wnt target genes (b)56. Image from van der Flier and Clevers (2009)1. 
 
The non-canonical pathways – Wnt/Planar Cell Polarity (PCP) and Wnt/Ca2+ - are 
less well known and its activation is independent of LRP5/656.  
PCP controls coordinated and uniformly polarized cellular behaviours and is a 
critical process for many fundamental developmental processes in mammals, such as the neural 
tube closure and the determination of left-right asymmetry, taking part in the regulation of the 
actin cytoskeleton, namely the organization of polarized structures and directed migration60,61. 
Wnt signalling is required in PCP pathway, although its mechanism still remains unknown60. 
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The Wnt/Ca2+ pathway shares some components with the PCP pathway and it’s 
based on the finding that some Wnt molecules and Fz receptors can stimulate the intracellular 
release of Ca2+. The calcium’s release and intracellular accumulation will lead to the activation 
of Ca2+ sensitive proteins, such as protein kinase C (PKC) and calcium/calmodulin-dependent 
kinase (CamKII). During embryogenesis, this pathway is known to play a role in the negative 
regulation of dorsal axis formation, promotion of the ventral cell fate and also in heart 
formation61. 
 
Regarding the adult small intestine, the Wnt/β-catenin pathway functions as the switch 
between epithelial cells’ differentiation and proliferation, being also essential for the 
maintenance of the crypt progenitor compartments1. Wnt is secreted by Paneth cells and the 
surrounding myofibroblasts and is expressed in a gradient along the crypt-villus axis, with a 
higher expression observed at the bottom of the crypts51,62,63.  
There are several Wnt target genes reported in the literature, such as c-Myc, involved 
in cell proliferation64, Sox9, required for Paneth cells’ differentiation,  and Lgr5, involved in 
the transmission of extracellular signals65. Lgr5 is a receptor for R-spondins – Wnt agonists –, 
and this two-protein complex can associate with the complex that activates the canonical 
pathway, amplifying the effect of Wnt/ β-catenin signalling51,52,58,66. 
 
1.3.2. BMP pathway 
BMPs are a group of conserved growth factors that form the largest subgroup of the 
Transforming Growth Factor β (TGFβ) superfamily. These factors are important morphogens 
that play a key role during embryogenesis and development, taking part in cell growth, 
apoptosis, differentiation, and also help in the maintenance of tissue homeostasis in adult 
organisms58,67,68,69. These proteins are synthetized as precursors with 400-500 amino acids (aa) 
and their structure is highly conserved. Once cleaved, the mature form of the protein (50-100 
aa) contains seven cysteine residues. While 6 of these residues form 3 dissulfide bonds, the 
other cysteine is responsible for another dissulfide bond with a cysteine residue in another BMP, 
forming a dimer that’s biologically active67,68,69,70. 
 
Similar to Wnt, BMP can also signal through a canonical (SMAD dependent) and non-
canonical (SMAD independent) pathway68 (Figure 1.10). 
In the canonical pathway, the BMP receptor is a type I/II heterodimer. BMP first binds 
to the type I receptor and then, by affinity, the type II receptor binds to the complex and GS 
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domain will be phosphorylated by the type II receptor’s constitutive kinase, thus converting the 
type I receptor into its active form58. Once the BMP complex is activated, it’s the 
phosphorylation of SMAD proteins that will allow the BMP signalling. Namely, Receptor 
associated SMAD (R-SMAD) 1, -5 and -8 will be recruited by BMP protein complex, and once 
phosphorylated forms a complex with Co-SMAD4, allowing the translocation of the complex 
to the nucleus and the transcription of genes specifically regulated by BMPs58,67,70,71,72.  
 
 
 
Figure 1. 10. Representation of the BMP pathway. The signal transduction initiates when BMP binds to type I 
or II serine/threonine kinase receptors. This association will result in the phosphorylation of R-SMADS (SMADS1, 
5 and 8), that will associate with SMAD4. This complex will then translocate to the nucleus, where it further 
associates with coactivators or corepressors to regulate gene expression. Regulation of gene expression can also 
be achieved through non-canonical pathways, such as MAPK cascade. BMP signalling is modulated intracellularly 
(e.g., microRNAs, phosphatases and I-SMADS), extracellularly (e.g., Noggin) and also by co-receptors in the 
plasma membrane (e.g., Endoglin). Image adapted from Wang et al. (2014)68. 
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SMAD-independent BMP signalling, such as MAPK (p38 Mitogen-Activated Protein 
Kinase) pathway, is less well known and, once it’s initiated, BMPs are able to play a role on 
cell survival, apoptosis, migration and differentiation67. 
 
Depending on the pathway that interacts with BMP signalling pathway, the cellular 
response can change72. The most well studied interaction is with Wnt pathway, which 
contributes to the proliferation and maintenance of the epithelium in the small intestine, as 
stated in the previous section. In the small intestine, BMPs - produced by epithelial 
myofibroblasts - act as a differentiation signal and as an antagonist of Wnt signalling in the 
crypts, by restricting the nuclear localization of β-catenin58,72,73. 
 
At embryonic stages of mouse development, between E7.5 and E10.5, BMPs and their 
receptors are widely expressed7. In adult small intestine, BMP expression is stronger in the 
mesenchyme at the villus tips, while the crypts express BMP antagonists, in order to provide 
ISC the optimal niche for proliferation (Figure 1.8). This signalling is also needed for the 
terminal differentiation and maturation of precursors of the secretory lineage36,58,72. 
 
1.3.3. Notch pathway 
Notch is a simple signalling pathway involved in several processes in embryonic and 
adult tissues, such as cell proliferation and differentiation, regulation of stem cell function and 
establishment of cell boundaries1,19,25,74,75. This pathway acts in a very unique way, given the 
fact that its receptors are transmembrane proteins. Thus, only the neighbour cells receive the 
signal – a process called lateral inhibition25,74,76. In mammals, there are 4 Notch receptors – 
Notch 1-4 –, and 5 Notch ligands, Delta-like (DLL) 1, 3 and 4, and Jagged (JAG) 1 and 
225,74,77,78. Both the receptors and the ligands have extracellular domains, in which EGF-like 
repeats are the main elements. 
 
Notch receptors have an ectodomain termed Notch Extra-Cellular Domain (NECD) 
and a membrane-tethered intracellular domain (NTM). This heterodimer, which accumulates at 
the plasma membrane, interacts in a Ca2+ dependent and non-covalent manner79. 
In order to activate the Notch signalling, a series of three cleavages are needed. Once 
Notch is cleaved at the extracellular “S1” site, a process that occurs in the trans-Golgi network, 
the cell surface receptor becomes functional.  Then, a second cleavage, ligand dependent, takes 
place, now at the “S2” site, giving origin to NEXT (Notch Extracellular Truncation), a 
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membrane bound activated form. Finally, NEXT is further processed at the intramembraneous 
“S3” and “S4” sites and the active Notch Intracelular Domain (NICD) is released74,78,79,80,81.  
NICD acts as a transcriptional regulator and will be translocated to the nucleus, where 
it will bind with the CSL DNA-binding protein and with the Mastermind/Lag-3 co-activator, 
activating the expression of Notch target genes75,78,79. In case NCID is absent, CSL binds to co-
receptors in order to prevent the transcription of Notch target genes78.These series of events are 
portrayed in Figure 1.11. 
 
 
 
Figure 1. 11. Notch signalling pathway. Notch signalling is activated by three sequential cleavages: S2 is 
catalysed by the ADAM-family of metalloproteases and the S3/S4 by γ-secretase. Upon NEXT processing, NICD 
will translocate intro the nucleus and Nβ, a small peptide, is released74,79. Image adapted from Schweisguth 
(2004)79. 
 
 In the adult small intestine, Notch signalling molecules are expressed in stem cells as 
well as in the crypt epithelial cells7,81. However, at embryonic stages (between E13.5 and 
E18.5), expression of Notch ligands and receptors was reported to occur on the mesenchyme82. 
The Notch pathway is the only one that plays two roles in the small intestine: together 
with Wnt, it’s involved in the maintenance of cell proliferation in the crypt compartment, and 
it plays a major role in cell fate decisions, by inducing differentiation towards the absorptive 
enterocyte lineage1,7,58.  
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1.3.4. Hh pathway 
The Hh signalling pathway is crucial for the correct development of the embryo and 
its deregulation can give rise to birth defects as it plays a role in the patterning of different 
structures, such as the neural tube, lungs and the gastrointestinal tract. In adult organisms, Hh 
pathway contributes to cell differentiation, proliferation and maintenance, and thus its 
deregulation can lead to cancer83,84. 
 
In mammals, the Hh family comprises three members: Sonic Hedgehog (Shh), Indian 
Hedgehog (Ihh) and Desert Hedgehog (Dhh)58,85,86. The proteins of this family are synthetized 
as 45 kDa precursors that undergo autoproteolytic cleavage to produce an N-terminal signalling 
protein with 19 kDa with lipid modification – a palmitoyl group at its N-terminal and a 
cholesterol modification at the C-terminal. These modifications will control the binding of the 
Hh ligands to the membrane and its mobility, as well as facilitate long-range signalling despite 
the ligands poor solubility83,85. The active Hh protein secretion is mediated by two proteins – 
Dispatched (Disp), a multi-pass transmembrane protein, and Scube2, a secreted glycoprotein. 
This complex will bind to the C-terminal cholesterol group, allowing the release of Hh from 
the plasma membrane (Figure 1.12 A)58,85,86. 
  
 
Figure 1. 12. Hh signalling pathway. The precursor of the active Hh protein undergoes some modifications until 
its active form is secreted with the help of proteins Disp and Scube2 (A). In the absence of Hh ligand, Ptch 
catalytically inhibits the activity of Smo (B). Ptch is degraded once Hh binds to it and, as a consequence, Smo is 
activated and the Hh signal is tranduced to the cytoplasm, allowing the transcription of Hh target genes (C)87. 
Image from Cochrane et al. (2015)85. 
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Activation of the Hh pathway involves several cellular and molecular mechanisms 
(Figure 1.12 B and C). Hh receptor Patcher (Ptch), a 12-trasmembrane protein, inhibits Hh 
signalling by repressing Smoothened (Smo), a 7-trasmembrane receptor83,84,85. However, once 
Hh binds to Ptch, this complex is internalized and degraded, resulting in the accumulation of 
Smo in cilia and consequent Hh signalling activation83. Smo mediates the action of Gli proteins: 
in the absence of Hh ligands, Gli proteins undergo proteosomal degradation into their repressor 
form and will supress the expression of Hh target genes. If Smo is allowed to signal 
downstream, Gli proteins will act as transcription factors and regulate the target genes 
expression85,86,,88. 
 
Regarding spatial expression in the adult small intestine, Shh is expressed at low levels 
by some epithelial cells at the bottom of the crypts, while Ihh is expressed at the base of the 
villi and, at more reduced levels, at the top of the villi58. At embryonic stages, where Hh 
signalling in involved in left-right axis specification and in the regulation of villi formation, the 
expression of the Hh ligands varies: between E11.5 and E12.5, Shh and Ihh are expressed 
through the endoderm. While Shh expression gets downregulated by E14.5, the expression 
levels of Ihh don’t change in the developing intestine, and by E18.5, both genes expression is 
confined to the intervillus epithelium83,89. During the small intestine’s development Hh 
signalling acts a sensor of epithelial integrity and, together with BMP, it also establishes a 
gradient along the crypt-villus axis to counter-act the proliferative force driven by Wnt 
pathway7,58. 
  
1.3.5. Eph/ephrin pathway 
Eph (Erythropoietin-producing hepatocellular) receptors are type I transmembrane 
proteins that belong to the superfamily of transmembrane Tyr kinase receptors90,91. These 
receptors are composed by three domains: an N-terminal glycosylated ligand-binding protein, 
a transmembrane region and an intracellular catalytic kinase domain90. Eph receptors are 
implicated in several biological processes, such as cell proliferation, adhesion and migration 
and cell morphology, playing a role in the spatial organization of different cell 
populations91,92,93. 
Ephs have high affinity to their ligands, the ephrins (Eph receptor interacting proteins), 
and interact with them through several sites on their N-terminal90. Like their receptors, ephrins 
are also transmembrane proteins and can be divided in two classes: class A ephrins, anchored 
to the membrane by glycosylphophatidylinositol (GPI), and class B, which have a 
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transmembrane segment and a short cytoplasmic region93,94. Once ligands and receptors bind, 
Eph clustering leads to the autophosphorylation of intracellular tyrosine residues. These 
residues, through the interaction with other proteins, will then trigger the downstream signalling 
pathway90. 
 
One of the prominent features of the Eph/ephrin pathway is the bidirectional 
signalling, meaning that both ligands and receptors are able to transduce a signalling cascade90. 
It’s these Eph/ephrin bidirectional interactions that play a role in the homeostasis maintenance 
in the small intestine by controlling the cell positioning along the crypt-villus axis and the 
proliferation of progenitor cells91. Some of the pathway’s components are targets of the Wnt/β-
catenin pathway7, which regulates the expression of a number of ephrins in differentiated cells 
outside the crypt in a negative manner. On the other hand, Wnt/β-catenin promotes the 
transcription of Ephs, and this opposite gradient is responsible for the maintenance of the 
proliferative and differentiated compartments in the crypt-villus axis91,95. 
 
As shown in the previous sections, there is a complex network of genes and pathways 
regulating the small intestine’s development and homeostasis. It is also known that there are 
some proteins associated to ISC – ISC markers – but little is known about them and other 
putative markers. Thus, targeting specific genes can provide insights about their overall 
physiological functions. 
 
 
1.4. Cell lineage studies 
Cell lineage studies play a key role in developmental biology, since they allow to closer 
characterize the developmental potential of a pluripotent ESC or, in general, the capacity of one 
cell to give rise to its descendants96. 
Lineage tracing is one of the methods used for cell lineage studies and consists in the 
identification of all the progeny of a single cell. This is a key technique to understand tissue 
development, homeostasis and disease, and also a powerful tool to study stem cell properties in 
mammalian tissues, since it provides information into these cells behaviour in the context of 
the whole tissue or organism97. 
Although the most common techniques to perform lineage tracing experiments rely on the 
tamoxifen-inducible Cre-Recombinase enzyme and transgenic reporter mice98, other methods 
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can be used, such as e.g. the labelling with dyes and radioactive markers, genetic mosaics or 
the introduction of genetic markers by transfection or viral transduction, to name a few97. 
 
1.4.1. Cell ablation 
Targeting specific genes can provide insights into their overall physiological functions 
in vivo. However, when the aim is to gather information about the function of specific cell 
lineages or cell populations in whole organisms, techniques are less developed99.  
Cell ablation is one efficient method used to perform cell lineage studies and it 
involves the elimination of the cell population of interest. In order to achieve this, several 
techniques can be used, such as laser ablation, aspiration and microdissection, with the most 
efficient being genetic cell ablation. This technique consists in the expression of a cytotoxic 
gene under the control of a tissue specific promotor or a protein that triggers the death in cells 
sensitive to the cytotoxic products99,100.  
There are several cell ablation systems described in the literature, such as the Gfap-
thymidine kinase transgenic mouse – where upon administration of the drug gancyclovir, Gfap-
positive cells were ablated101 – and the overexpression of the pro-apoptotic protein Bax in 
neural precursors102. Another substance used to achieve genetic ablation is DT (Diphtheria 
Toxin), where to avoid nonspecific cell damage, one of the strategies used consists in the 
expression of the toxin receptor in the targeted cell type. This way, the toxin is not harmful to 
the rest of the organism and will only ablate the specific cells in which the receptor is present 
at the surface99,103. 
 
1.4.2. Diphtheria Toxin mediated cell ablation 
Diphtheria Toxin, synthetized by pathogenic strains of Corynebacterium diphtheria, is 
a single polypeptide with 535 aa and has two fragments – A and B103,104,105. Both them are 
essential for the intoxication process. Fragment B’s (DT-B) role is the binding of the toxin to 
its cell surface receptor (HB-EGF precursor)103,104, while DT-A – a protein with 21 kDa105 - is 
responsible for the toxicity104. One of cytotoxic pathways described for DT is portrayed in 
Figure 1.13 where, once in the cytoplasm, DT-A will catalyse the inactivation of elongation 
factor 2 (EF-2), which will lead to the end of protein synthesis and thus induce the apoptosis of 
the cell99. 
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Figure 1. 13. Schematic representation of the DT entry into cells. After DT-B (yellow) binds to the HB-EGF 
precursor (1), the toxin is internalized into early endosomal vesicles (2). Later, and due to the acidic conditions of 
the late endosome, DT-A (red) is translocated to the cytosol where it catalyses the transference of the ADP-ribose 
moiety of nicotinamide adenine dinucleotide (NAD+) to a modified histidine residue on polypeptide chain 
elongation factor 2 (EF-2), inactivating it (3)99. Image adapted from Murphy (2011)103. 
 
 Since DT-A is a well characterized inhibitor of protein synthesis and translation 
inhibition is the earliest indication of intoxication, the process described previously was taken 
as the only mechanism of DT toxicity106. However, a second cytotoxic mechanism was 
proposed by Chang et al. (1989), where they hypothesized that DT might activate a suicide 
pathway dependent of endogenous nucleases, similarly to other cytotoxic models described. 
Besides the toxin-associated deoxyribonuclease activity enhancement in the presence of Mg2+ 
and Ca2+, these authors also reported that the nuclease activity was mediated by DT-A107. This 
evidence led to the conclusion that the cytolysis induced by DT is not a consequence of protein 
synthesis inhibition106. In other studies, Lee et al. (2005) reported that DT is able to degrade 
double-stranded DNA (dsDNA) through non-processive and endonucleolytic attacks, without 
specificity for the nucleotide sequence, and that nuclease activity can lead to the death of the 
target cells by itself108. 
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The toxin’s subunit A has high toxicity and only one molecule of this subunit in the 
cytosol is enough to cause cell death. Due to this, even a low expression of DT-A can ablate 
the target cells with high efficiency. On the other hand, if expressed non-specifically, the toxin 
can give rise to unwanted effects on the organism embryogenesis and morphogenesis99. The 
basic principle of this conditional cell ablation technique is portrayed in Figure 1.14.  
 
 
 
1.4.3. Diphtheria Toxin Receptor 
The heparin-biding epidermal growth factor-like growth factor is a O-glycosylated 
protein with 22 kDa, isolated for the first time by Higashiyama et al. (1991)109 from the 
conditioned medium of a human macrophage-like cell line110. 
HB-EGF belongs to the EGF family of growth factors, divided in four groups 
according to which ligand the proteins bind. In the first group, EGF, TGF-α and amphiregulin 
bind specifically to EGF receptor (EGFR) while the proteins of the second group, which 
includes HB-EGF, betacellulin and epiregulin bind to EGFR and ErbB4. The last two groups 
include the neuregulins (NRG1-4), where NRG1 and NGR2 bind to both ErbB3 and ErbB4, but 
Figure 1. 14. Schematization of the DT-mediated cell ablation. Transgenic mice carry the gene that encodes the 
DT receptor preceded by a STOP cassette flanked by two loxP sites. Upon Tamoxifen administration, the STOP 
cassette is removed and the target cells start to express the receptor, making them sensible to the DT. 
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NRG3 and NRG4 only bind to ErbB4111. These proteins, along with their receptors, contribute 
to the development, morphonogenesis and maintenance of homeostasis in the organism111. 
When the HB-EGF binds and activates its ligands, the protein is able to participate in 
mitogenic, chemoattractant and cell survival activities110. Besides this, it also plays a role in 
tumour formation, heart development and maintenance, and skin wound healing111. HB-EGF is 
the only known protein of the family that plays a significant role in growth and development110. 
Several authors, such as Luetteke et al. (1999)112 and  Iwamoto et al. (2003)113  have described 
that HB-EGF knockout (KO) mice died shortly after birth while KO mice for other growth 
factors belonging to the same family, like TGF-α, EGF and amphiregulin, did not110,114.  
Initially, HB-EGF is synthetized as a transmembrane precursor protein. The 
membrane-anchored form of the protein (proHB-EGF) is formed by a pro domain (propeptide 
and signal peptide) followed by five domains: heparin-binding, EGF-like, juxtamembrane, 
transmembrane and cytoplasmic, as shown in Figure 1.15. The soluble form of the protein 
(sHB-EGF), a potent mitogen and chemoattractant for a number of different cell types, is 
obtained through a protease cleavage110,111. 
 
 
Figure 1. 15. Structure of HB-EGF protein. The mature form of HB-EGF (sHB-EGF) consists of a propeptide, 
a heparin binding domain and an EGF-like domain. sHB-EGF is generated by proteolytic processing at the 
juxtamembrane domain (red arrow). The N-terminal propeptide is also processed (black arrow), but the biological 
significance of this processing is not clear. Numbers in the figure indicate amino acid residues from the N-terminus. 
Image from Iwamoto et al. (2006)114. 
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It’s the proHB-EFG that works as the receptor for the DT-A. However, this 
protein/ligand recognition happens in humans, but not in mice. This is due to the 3 amino acid 
sequence variation between human and mouse in the EGF-like domain, being this the domain 
responsible for the binding of DT-A with proHB-EGF100,110. For this reason, the mice receptor 
has a lower affinity (about 105) to DT-A, which consequently leads to a higher DT-A resistance 
in mice. One of the strategies to overcome this is to create a recombinant mice strain that express 
a human or simian DT-A receptor (termed iDTR, inducible Diphtheria Toxin Receptor) in order 
to obtain specific mice cells DT-sensitive100,104. 
 
 
1.5. Id2 protein 
 Inhibitor of differentiation or inhibitor of DNA binding (Id) proteins belong to a highly 
conserved group of molecules that play major roles in various organisms, such as 
differentiation, cell cycle control and cell line commitment115,116. These proteins have a small 
peptide chain that possesses a helix-loop-helix (HLH) motif, and intervene in the dimerization 
with other basic HLH proteins, mostly E proteins. However, since Id proteins lack some basic 
aa essential for DNA binding, they inhibit E proteins in a negative-dominant manner by forming 
non-functional heterodimers, which means that genes with the E-box sequence in their 
regulatory elements are repressed115,116,117. 
 Amongst other functions, Id proteins play an important role in stem cell maintenance, 
vasculogenesis, tumorigenesis and metastasis, due to their capability of inhibiting the 
differentiation of progenitors of different cell types, promoting the cell-cycle progression, 
delaying cell senescence and assisting cell migration116. 
 
 In mammals, four Id proteins have been identified – Id1, Id2, Id3 and Id4 -, and their genes 
are differentially expressed in various cell types116,118. Id genes transcription is controlled not 
only by transcription factors but also through signalling pathways, such as BMP, cytokines and 
ligands of T cell receptors116.  
 
 Unlike Id2, whose transcription is limited to a few cell types, being neuronal cells one of 
them, Id2’s messenger RNA (mRNA) is ubiquitously expressed in Mus musculus115,118,119. The 
protein, being encoded by a gene in chromosome 12, is expressed in tissues undergoing active 
morphogenic activities, such as the intestine, lungs and kidneys118. Contrarily to what happens 
in other tissues, the Id2 pattern of expression does not overlap with Id1 and Id3 in tissues 
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derived from primitive gut. Here, Id2 is detected within the epithelium, while Id1 and Id3 
expression is detected in the mesenchyme that surrounds the epithelium118.  
  
 During gut organogenesis, Id2’s mRNA is expressed in the epithelium of the gastrointestinal 
tract120. Jen et al. (1996) showed the expression pattern of Id2 during mouse embryonic 
development. By E10.5, Id2 is located in the intestinal endoderm and by E14.5, as the 
mesenchyme becomes gradually segregated into two areas – one will give rise to muscle layers 
and the cells close to the epithelium will orientate parallel to it –, Id2 is detected in the peripheral 
muscle cells. During villi formation, around E16.5, very low levels of Id2 expression are 
detected in the intestine118. Moreover, the Id2 gene product is thought to regulate the 
differentiation and cell division of enterocytes120, since the genetic ablation of Id2 prevents the 
differentiation and the cell arrest of enterocytes when the crypt-villus axis is formed, and thus 
suggesting that this gene is involved in the lineage specific differentiation of intestinal cells121. 
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2. OBJECTIVES 
 Until it reaches its mature form, the small intestine goes through morphologic and genetic 
changes during mouse embryogenesis. However, there is still not much information about the 
molecular programs that trigger such changes. 
 Plausible candidates worth further investigation are genes highly expressed in the 
embryonic small intestine but absent in adult ISC, and vice-versa, and genes that regulate the 
expression or function of signals that define the ISC identity, such as the Wnt and BMP 
pathways. 
 
 2.1. Project background 
Previous work conducted at the Developmental and Stem Cell Biology Laboratory pointed 
towards a suitable candidate to study – the Id2 gene – in order to underlie the molecular 
mechanisms behind the formation of a highly complex structure. 
RNA sequencing of ISC and embryonic intestinal EpCam+ cells showed different Id2 RNA 
levels in these two conditions – embryonic intestinal cells at E12.5 and E14.5 showed a similar 
transcriptome, while almost no Id2 RNA was detected in ISC. These results suggest a different 
transcriptional signature between the embryonic small intestine’s epithelium and adult ISC. 
Another evidence that pointed to Id2 being a part of the molecular program responsible for 
the changes from the embryonic to adult stage were fluorescence activated cell sorting (FACS) 
experiments, where intestinal epithelial cells were isolated from Id2 wildtype (wt) and Id2 KO 
mouse embryos at E11.5. These results showed the appearance of an Lgr5+ cell population 
(about 30%) in KO mice embryos, which did not occur in the wt. Wildtype mice embryos 
present no Lgr5 expressing cells until E13.5, meaning that Id2 could be involved in the 
induction of the expression of this ISC marker two days earlier, evidencing a possible Id2 role 
in the embryonic development of the small intestine. 
 
2.2. Goal 
The goal of the present study was to perform the ablation of Id2+ cells during the 
development of the small intestine using DT. The DT-mediated cell ablation has not been 
described on embryos so far, thus, it was important to establish the ablation system during 
mouse embryogenesis. Moreover, with the development of the cell ablation system it was then 
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possible to study the genetic difference between wildtype mouse embryos and Id2-ablated 
mouse embryos.  Following the results in Id2 KO mouse embryos, one of the aims is also to 
gain more insight on the possible influence Id2 might have in the appearance of the Lgr5+ cell 
population.
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3. METHODOLOGY 
 This study focuses on the ablation of a specific cell population during the development of 
the embryonic small intestine, the Id2+ cell population, as well as getting some insight about 
the consequences of this ablation for the surrounding cell populations. 
 In this experience, a mice strain expressing a Diphtheria Toxin receptor under the control of 
the target gene promoter was obtained, thus allowing the ablation of the cell population of 
interest upon administration of the toxin.  
 Immunostaining on histological sections was performed in order to assess the expression 
and location of the DT receptor, as well as the apoptosis caused by the ablation system itself. 
Sections were also stained in order to visualize the morphological changes derived from the 
treatment with the toxin. 
 Changes in the Id2+ cell population after ablation were analyzed through FACS and some 
specific populations were isolated for further quantitative PCR (qPCR) analysis in order to 
assess the genetic differences between them. 
 
3.1. Tamoxifen preparation and administration 
Tamoxifen (Sigma) was dissolved to a final concentration of 15 mg/ml in peanut oil (Sigma) 
using sonication. 
Pregnant female mice were anaesthetized with isoflurane (Forene® 100% (v/v), AbbVie) 
and 100 μg of tamoxifen per 30 g of body weight (bw) was administrated by oral gavage. 
 
3.2. DT administration 
Before injection, pregnant females were anaesthetized with isoflurane (Forene® 100% 
(v/v), AbbVie). 150 μl of DT (1 μg/ml, from Corynebacterium diphtheriae, Sigma-Aldrich) – 
30 ng/ g bw – were administrated by intraperitoneal injection. 
 
3.3. Sampling 
Pregnant female mice were sacrificed by hypoxia with CO2, followed by cervical 
dislocation.  
Mice were dissected in order to expose the abdominal cavity and uterus was removed and 
placed in PBS 1x. Embryos were removed from the amniotic sac and placed in PBS 1x, where 
they were decapitated and organs were collected. This procedure was made under a Leica M80 
(Leica Microskopie + systeme GmbH, Germany). 
Embryos were then prepared for further histological experiments. 
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3.4.  Western Blot 
Liver protein extracts from previously genotyped mice were separated by SDS-PAGE. 
Based on the target protein size (22 kDa), a 15% acrylamide gel was chosen to separate the 
samples. Protein separation was made at 85 V for 5 minutes (min), so the samples could enter 
the gel, and after it at 120 V for 1 hour (h). 
After separation, the proteins were transferred to a Immubilon®-P Transfer Membrane 
(Merk Millipore), previously soaked in 100% methanol (MeOH) (Carl Roth CmbH, Germany), 
using Trans-Blot® SD Semi-Dry Transfer Cell (BioRad). Transference was done at 75 mA for 
1.5 h. In order to confirm that the transference was successful, Ponceau red was added. 
The membrane was blocked with 5% milk in PBS 1x for 1 h at room temperature (RT), to 
prevent unspecific reactions between antibodies and the membrane. Primary antibody Goat 
anti-Hbegf (1:2000, Santa Cruz) was added and the membrane was left to incubate overnight 
(O/N) at 4ºC. After the first incubation, the membrane was washed 3 times for 5 min with PBS 
1x and incubated with Donkey anti-Goat IgG-HRP antibody (1:3000, Santa Cruz) for 1 h at RT. 
After new washing, as previously described, a mix of 750 µl of SuperSignal® Pico 
Luminol/Enhancer Solution (Thermo Scientific) and 750 µl of SuperSignal® Pico Stable 
Peroxidase Solution (Thermo Scientific) was dropped on the membrane. 
Visualization of the membrane was done using ChemiDoc™ MP System (BioRad). 
 
3.5. Genotyping 
For genotyping, a piece of ear (adult mice) or limbs/tail (embryos) was collected. To obtain 
gDNA, samples were treated with 75 µl of alkaline lysis buffer and put at 95ºC with agitation 
(Thermomixer Comfort, Eppendorf) for 20 min. After this, samples were kept at 4ºC for 20 min 
for inactivation, followed by the addition of 75 µl of neutralizing buffer. Finally, samples were 
centrifuged at 13000 rpm (HERAEUS PICO 21 Centrifuge, Thermo Scientific) for 2 min. 
 
The genotyping was done using the Polymerase Chain Reaction (PCR) technique. Starting 
with a small amount of template DNA, this process allows the in vitro synthesis of a large 
amount of a specific DNA sequence. There are some compounds needed for the reaction to 
occur: a DNA template containing the sequence to be amplified; a DNA polymerase, which has 
to be thermostable to withstand this process’s high temperatures; the four deoxynucleotide 
triphosphates (dNTPs) – adenine (A), cytosine (C), guanidine (G) and thymidine (T); and a pair 
of small pieces of single-stranded DNA, called primers, that are complementary to the target 
sequence122. 
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The reaction starts with a denaturation step, which will rise the temperature up to 95ºC, 
denaturating the DNA template through the elimination of its secondary structures. Next, 
there’s the annealing step in which the primers bind to the complementary DNA strain. In this 
part of the process, the temperature slowly decreases to temperatures between 50ºC and 70ºC. 
Once the biding between the primers and the DNA template is established, an elongation step 
takes place. The synthesis of new strands of DNA occurs at 72ºC, which is the optimal 
temperature of Taq polymerase. This enzyme will start the elongation at the 3’ end of each 
primer, adding the dNTPs in a sequential manner, according to the DNA template. The 
repetition of these steps in a limited number of cycles (usually 20-35) will increase the amount 
of target DNA in an exponential manner, as the amount of DNA duplicates in each cycle122. 
 
 The sequences of the primers used in the mice genotyping made along this project are shown 
in Table 3.1. 
 
Table 3. 1. Sequences of the specific primers for genotyping, forward (Fw) and reverse (Rv), used in the 
amplification of gene fragments, as well as the length of the PCR product. 
Gene Primer sequence (5’→ 3’) PCR product size (bp) 
dsRed 
Fw: CAC CCA GAC CGC CAA GCT G 
Rev: GAG TCC TGG GTC CAC GGT CAC 
190 
Hprt-Cre mut 
Fw: GCG GTC CAG TAA AAA CTA TC 
Rev: GTG AAA CAG CAT TGC TGT CAC TT 
120 
Hprt-Cre wt 
Fw: CAC AGT AGC TCT TCA GTC TGA TAA AA 
Rev: TTT CTA TAG GAC TGA AAG ACT TGC TC 
200 
Id2 wt 
Fw: CTT CCT CCT ACG AGC AGC AT 
Rev: CTC ACC TGC AAG GAC AGG AT 
370 
Id2 mut 
Fw: CTC ACC TGC AAG GAC AGG AT 
Rev: GCT CCT GGA CAG GAA TCA AG 
650 
iDTR mut 
Fw: GAA AGT CCG TGA CTT GCA AGA GG 
Rev: CTC TCA GTG GGA ATT AGT CAT GCC 
450 
iDTR wt 
Fw: GGA GCG GGA GAA ATG GAT ATG AAG 
Rev: CCA AAG TCG CTC TGA GTT GTT ATC 
650 
 
 
 The cycling conditions used for amplification of the gene fragments described above are 
shown in Tables 3.2 to 3.6. 
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Table 3. 2. PCR cycling conditions for amplification of Hprt-Cre wt and mut. 
Temperature (°C) Duration (min or seconds, sec) Number of cycles 
94 3 min  
94 25 sec 
28 59 30 sec 
72 15 sec 
4 Hold  
 
 
Table 3. 3. PCR cycling conditions for amplification of iDTR wt.  
Temperature (°C) Duration (min or sec) Number of cycles 
94 3 min  
94 25 sec 
28 60 30 sec 
72 30 sec 
4 Hold  
 
 
Table 3. 4. PCR cycling conditions for amplication of iDTR mut. 
Temperature (°C) Duration (min or sec) Number of cycles 
94 4 min  
94 15 sec 
28 60 15 sec 
72 45 sec 
72 2 min  
4 Hold  
 
 
Table 3. 5. PCR cycling conditions for amplification of Id2. 
Temperature (°C) Duration (min or sec) Number of cycles 
94 4 min  
94 15 sec 
35 58 10 sec 
72 45 sec 
72 2 min  
10 Hold  
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Table 3. 6. PCR cycling conditions for amplification of dsRed. 
Temperature (°C) Duration (min or sec) Number of cycles 
94 1 min  
94 25 sec 
31 60 30 sec 
72 40 sec 
4 Hold  
 
 
 Reaction mix used in these amplifications was as described in Table 3.7. 
 
Table 3. 7. Reaction mix used in amplification of interest fragments by PCR. Primers were the ones described 
in table 2.1. (Sigma Aldrich), 10x Thermo Pol® Reaction Buffer was from New England BioLabs® Inc., 
GeneAmp dNTP Blend (100 mM) from Life Technologies™, Taq Polymerase was homemade (Institute of 
Molecular Biologx, Germany) and gDNA was obtained from the ears of adult mice and limbs/tail of mouse 
embryos.  
Reaction component Volume per reaction (μl) 
10x Thermo Pol® Reaction Buffer 1.5 
10 mM dNTPs 0.3 
100 mM Primer FW 0.1 
100 mM Primer RV 0.1 
miliQ water 12 
Taq Polymerase 0.1 
 
 
After amplification, samples were loaded into a 2% agarose gel and ran at 120 V for about 
45 min. The genotyping results were visualized using ChemiDoc™ MP System (BioRad). 
 
3.6. Histochemistry 
In this study, different histochemistry techniques were used – immunostaining and staining 
with hematoxylin and eosin (H&E). While the first allows to determine the location, distribution 
and expression of a target protein on a tissue section123, hematoxylin and eosin staining is used 
mainly for phenotypical characterization. In the immunostaining approach, labelling is 
achieved through antibodies. In this technique, a primary antibody is firstly used to bind to the 
target protein, and is later detected by a secondary antibody. The target protein is then localized 
due to the pre-labelling of the second antibody with a fluorescent molecule123. Hematoxylin and 
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eosin staining depends on the properties of the dyes – hematoxylin, a blue-purple colour reagent 
that stains nucleic acids, and pink eosin, that stain proteins in a nonspecific manner124,125.  This 
technique allows the observation of a range of cytoplasmic, nuclear and extracellular matrix, 
providing key structural information124. 
 
3.6.1. Tissue processing 
 Embryos collected as described in section 3.1 were prepared for cryosections and 
paraffin sections. 
 
3.6.1.1. Cryosections 
Embryos were fixed in 1% formaldehyde (FA, Sigma-Aldrich) at 4 ºC for 20 
min. After two washes with PBS 1x for 5 min, embryos were equilibrated in 30% sucrose 
(Sigma Aldrich, Germany) solution O/N and embedded in cryo medium (Surgipath FSC22 Blue 
Frozen Section Compound, Leica). 
Sections with a thickness of 10 μm were prepared with Leica Cryostat 
CM3050S (Leica Microskopie + System GmbH, Germany) and mounted in SuperFrost Ultra 
Plus® glass slides. The samples were kept at -80ºC until further experiments. 
 
3.6.1.2. Paraffin sections 
Collected embryos were fixated in 2% paraformaldehyde (PFA, Sigma-
Aldrich) O/N and washed twice with cold PBS 1x for 10 min each. For dehydration, embryos 
were incubated at RT for 15 min in 50% and 70% MeOH (in PBS 1x), and then transferred to 
100% MeOH (Carl Roth GmbH, Germany) and incubated O/N at 4 ºC. Paraffin embedding of 
the mouse embryos begun after the incubation in two changes of xylol (Carl Roth GmbH, 
Germany) for 10 min each, after which the embryos were transferred to paraffin at 58 ºC O/N 
and the blocks were prepared in Leica EG1150 H Paraffin Embedding Center (Leica, 
Microkopie + System GmbH, Germany). 
The blocks were sectioned (10 μm sections) in a Leica RM 2255 Microtome 
(Leica Microskopie + System GmbH, Germany), mounted in SuperFrost Ultra Plus® glass 
slides and kept at 4ºC. Before any histological procedure, the sections were placed at 58ºC 
during 1 h for the paraffin to melt. 
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3.6.2. Immunostaining 
Cryosections were equilibrated in PBS 1x and fixation was done with 1% FA for 10 
min. After two washings with PBS 1x for 3 min each, tissue sections were blocked with 5% (in 
PBS 1x) of animal serum (Table 3.8), with special attention to the species of origin of the 
serum, which should be the same in which the secondary antibody was produced, for 1 h at RT. 
 
Table 3. 8. Composition of the blocking solutions for each one of the target proteins - EpCam, HB-EGF and 
H2AX. 
Target protein Composition Animal serum 
EpCam - 50 μl of 0.1% Triton-X 
- 250 μl of 100% animal serum 
- 700 μl of PBS 1x 
Goat 
HB-EGF Donkey 
H2AX 
- 50 μl of 100% animal serum 
- 1 drop of M.O.M™ Mouse IgG Blocking 
Reagent (Vector Laboratories, Inc) 
- 38.5 μl of AffiniPure Fab Fragment 
Donkey Anti-mouse IgG (H+L) (Jackson 
ImmunoResearch Laboratories, Inc.) 
- 850 μl PBS 1x 
Donkey 
 
 
After blocking, the samples were incubated with the primary antibody in blocking serum 
(Table 3.9) O/N at 4ºC. Then, samples were washed with PBS 1x 3 times for 5 min and 
incubated with the secondary antibody (Table 3.9) for 1 h at RT. Following the incubation with 
the secondary antibodies, samples were washed as previously described, embedded in Shandon 
IMMU-MOUNT™ (Thermo Scientific) mounting medium and allowed to dry at RT, covered 
with a cover slip and sealed with nail polish. 
Imaging was performed in AF7000 widefield system (Leica).  
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Table 3. 9. Composition of the primary and second antibody solutions used in the detection of the target 
proteins EpCAM, HB-EGF and H2AX. 
Target protein Composition Primary Antibody Secondary Antibody 
EpCAM 
- 1 μl of antibody 
- 50 μl of 100% goat serum 
- 950 μl PBS 1x 
Anti-Mouse 326 
(EpCam) PerCP-
eFluor® 710 (0.2 
mg/ml, eBioscience®) 
Alexa Fluor® 568 Goat 
Anti-Rat IgG (H+L) 
(2mg/ml, Life 
Technologies™) 
HB-EGF 
- 1 μl of antibody 
- 50 μl of 100% donkey serum 
- 950 μl PBS 1x 
Goat Policlonal 
Human Anti-Hbegf 
(0.2 mg/ml, R&D 
Systems™) 
Alexa Fluor® 647 
Donkey Anti-Goat IgG 
(H+L) (2mg/ml, Life 
Technologies™) 
H2AX 
Mouse Anti-Histone 
H2AX (Ser 139) (1 
mg/ml, Millipore) 
Alexa Fluor® 488 F(ab’) 
Donkey Anti-Mouse 
IgM (H+L) (2mg/ml, 
Invitrogen™) 
 
 
3.6.3. Hematoxylin and eosin staining 
Once the paraffin was melted in the sections of the mouse embryos, as mentioned 
in section 3.6.1.2, they were rehydrated through the following steps: 2 changes of xylol and 2 
changes of 100% ethanol, each with a 5 min duration, followed by a decreasing series of ethanol 
dilutions – 70%, 50% and 30% ethanol – for 2 min each and finally in distilled water for 5 min. 
In order to carry out the H&E staining, paraffin sections were stained in a 
hematoxylin solution (MORPHISTO) for 2 min, washed in warm running tap water for about 
30 sec, and, to terminate the hematoxylin staining, rinsed in distilled water, followed by 10 dips 
in a 95% alcohol solution. Counterstaining then followed with an eosin Y aqueous solution 
(Sigma-Aldrich) for 5 min. Dehydration was done through 95% alcohol for 1 min, followed by 
2 changes of 100% alcohol of 5 min each. Samples were then cleared in 2 changes of xylene, 5 
min each, mounted with Roti® medium (Carl Roth GmbH, Germany) and covered with cover 
slips.  
Imaging was performed in DM2500 microscope (Leica). 
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3.7. Isolation of intestinal cells 
3.7.1. Isolation of epithelial cells 
Once the embryos were isolated, as described in section 3.3, they were dissected to 
isolate the small intestine, under a Leica M80. 
Small intestine was placed in a tube with 500 μl PBS 1x and 1.5 μl of collagenase (50 
mg/ml) and left to digest for 10 min at 37ºC on a Thermomixer compact (Eppendorf AG, 
Germany), at 800 rpm. After digestion, 500 μl of PBS 1x were added and samples were 
centrifuged at 3000 rpm for 3 min ((HERAEUS PICO 21 Centrifuge, Thermo Scientific) to 
wash. Supernatant was removed and another washing step was performed. After washing steps, 
anti-EpCAM (Anti-Mouse 326 (EpCam) PerCP-eFluor® 710, 0.2 mg/ml, eBioscience) 
antibody solution (5 μl of antibody in 1 ml of 2% goat serum) was added and samples were 
mechanically crushed, in order to increase the antibody’s area of action, followed by incubation 
covered from light for 15 min at RT in a table-shaker See-Saw Roker SSL4 (Stuart Scientific, 
GB). To remove the excess EpCam antibody that didn’t bind to the cells, 1 ml of PBS 1x was 
added and samples were centrifuged for 3 min at 3000 rpm, supernatant was removed and the 
cell pellet was ressuspended in 300 μl of PBS 1x. 
Cell sorting was performed in High Speed Sorter BD Aria III Sorp and cells were sorted 
for qPCR analysis – 500 cells from each sample were sorted in 7 μl of buffer (1 μl of RNase 
inhibitor in 19 μl of dilution buffer). 
 
3.8.  Genetic analysis 
In order to compare the genetic profiles between embryos that had the Id2+ cell 
population ablated and the embryos that hadn’t, both cDNA synthesis and amplification were 
done using SMART-Seq v4 Ultra Low Imput Kit for Sequencing (Clontech Laboratories, Inc.). 
The protocols are briefly described in the points below and all the reagents used were supplied 
by the kit. 
 
3.8.1. cDNA synthesis and amplification 
To obtain cDNA from the samples previously sorted, cells were transferred to a 
0.2 ml RNase-free PCR tube and nuclease-free water was added up to 9.5 µl. 1 µl of 10x 
Reaction Buffer (Table 3.10) was added and samples were vortexed and incubated at RT for 5 
min. 
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Table 3. 10. Composition of 10x Reaction Buffer. 
Reagent Volume (µl) 
10x Lysis Buffer 19 
RNase Inhibitor 1 
   
In order to set up the control and test samples, the guidelines described in Table 
3.11 were followed. 
 
Table 3. 11. Guidelines for sample preparation. 
Components Volume (µl) 
10x Reaction Buffer 2 
Nuclease-free water Up to 8.5 
Diluted Control RNA - 
Sample 1 – 9.5 
Total volume 10.5 
 
 
Samples were maintained on ice and 2 µl of 3’ SMART-Seq CDS Primer II A (12 
µM) were added to the samples, followed by incubation in a TProfessional Trio Thermocycler 
(Biometra) at 72ºC for 3 min. Immediately after the incubation, samples were kept on ice for 2 
min. 
The Master Mix (Table 3.12) for the synthesis of first-stranded cDNAwas 
prepared at RT. 
 
Table 3. 12. Master Mix solution composition used for first-strand cDNA synthesis. 
Reagent Volume per reaction (µl) 
5x Ultra Low First-Strand Buffer 4 
SMART-Seq v4 Oligonucleotide (48 µM) 1 
RNase Inhibitor (40 U/µl) 0.5 
Total volume per reaction 5.5 
 
 
SMARTScribe Reverse Transcriptase (2 µl per reaction) was added to the mix prior to 
its use, and 7.5 µl of the Master Mix were added to each tube. Samples were preheated to 42ºC 
and amplification was done using the program described in Table 3.13. 
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Table 3. 13. Conditions used in first-strand cDNA synthesis. 
Temperature (ºC) Duration (min) 
42 90 
70 10 
4 Hold 
 
 
Amplification of cDNA was carried out by Long Distance PCR (LD-PCR). This 
technique allows the amplification of larger DNA fragments, which cannot be amplified using 
routine PCR methods or reagents126.  
Once cDNA was synthetized, all the reagents needed for its amplification – in order to 
increase the quantity of genetic material available for further work – except the enzyme, were 
put on ice and the following Master Mix was prepared (Table 3.14). 
 
 
Table 3. 14. Composition of the Master Mix solution used for cDNA amplification. 
Reagent Volume per reaction (µl) 
2x SeqAmp PCR Buffer 25 
PCR Primer II A (12 µM) 1 
SeqAmp DNA Polymerase 1 
Nuclease-free water 3 
Total volume per reaction 30 
 
 
In a fresh tube, 30 µl of Master Mix were mixed with 20 µl of first-stranded cDNA and 
the mixture was vortexed and spinned. 
cDNA amplification was performed in TProfessional Trio Thermocycler (Biometra) 
using the conditions described in Table 3.15. 
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Table 3. 15. Conditions used in cDNA amplification. 
Temperature (ºC) Duration Number of cycles 
95 1 min  
98 10 sec 
16 65 30 sec 
68 3 min 
72 10 min  
4 Hold  
 
 
3.8.2. Quantitative PCR 
Genetic analysis of the cells collected in section 3.6 was done by qPCR. 
Genes that take part in cell proliferation, apoptosis and stem cells markers, among 
others, were analysed. The sequences are shown in Table 3.16 and the Master Mix composition 
is described in Table 3.17. 
 
Table 3. 16. Specific primer sequences of the genes analysed by qPCR and corresponding annealing 
temperatures. 
Gene Primer sequence (5’→ 3’) 
Annealing 
temperature (ºC) 
Ascl2 
(Achaete-scute family bHLH 
transcription factor 2) 
Fw: GGA CGC AAT AAG CTA AGC ATC TG 
Rev: CCT GGG ACC CCG TAC CAG TCA 
61 
EpCam 
(Epithelial Cell Adhesion 
Molecule) 
Fw: TCC TTC CGG GGT ACT GGA AT 
Rev: TGA CTC ACC CGC CCCA 
58 
Id1 
(Inhibitor DNA binding/Inhibitor of 
differentiation 1) 
Fw: GCT GAA CTC GGA GTC TGA AG TCG 
Rev: CCG TTC AGG GTG CTG AGC 
60 
Id2 
(Inhibitor DNA binding/Inhibitor of 
differentiation 2) 
Fw: CTC TCC CAA TCT TTT GCA GGC 
Rev: GCA CTG GTT GTC TGA AAT AAA GCA 
57 
Id3 
(Inhibitor DNA binding/Inhibitor of 
differentiation 3) 
Fw: TGC AGC GTG TCA TAG ACT ACA TCC 
Rev: GAG CTC AGC TGT CTG GAT CG 
60 
Kcne3 
(Potassium voltage-gated channel, 
Isk-related subfamily, gene 3) 
Fw: GTG GGA CAT CCA CGA AGA GA 
Rev: TCC CGT TGG AAG TCT CCA TA 
56 
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Kcnq1 
(Potassium voltage-gated channel, 
subfamily Q, member 1) 
Fw: TGG AAG ACA AGG TGA CAC AAC TG 
Rev: GAC AGC AGC TGG TGG AGC AT 
59 
Lgr5 
(Leucine rich repeat containing G 
protein coupled receptor 5) 
Fw: GCA AAC TTC CCA GAG CTC AA 
Rev: CCC CAA ATG CAC AAC ACT GG 
56 
OneCut2 
(One cut domain, family member 2) 
Fw: GGA CGC AAT AAG CTA AGC ATC TG 
Rev:  CCT GGG ACC CCG TAC AGT CA 
60 
PUMA 
(p53 Upregulated Modulator of 
Apoptosis) 
Fw: CCT CAA CGC GCA GTA CGA GC 
Rev: CTC CAT TTC TGG GG CTC CAG G 
62 
Rspo1 
(R-spondin 1) 
Fw: CAG TCC TGC ACA ATG TGA AAT GAG C 
Rev: CGG AAA CCG CAC AGC TTC C 
60 
Rspo3 
(R-spondin 3) 
Fw: CAG CGA AGA ATG CAT CCT AAT GTC AG 
Rev: CTG GGC TTA CAT GAC AAA CAG CC 
61 
Sfrp5 
(Secreted frizzled-related protein 5) 
Fw: CTG GAC AAC GAC CTC TGC AT 
Rev: CAT CTG TTC CAT GAG GCC AT 
56 
Slc2a3 
(Solute carrier family 2 (facilitated 
glucose transporter), member 3) 
Fw: CAT CTC CAT TGT CCT CCA GC 
Rev: CAA TCG TGG CAT AGA TCG GT 
56 
Smoc2 
(SPARC related modular calcium 
binding 2) 
Fw: CCA TCC ACC GGA TAC TGC TG 
Rev: GTT GCT CAT ACC TTG TGG AGG 
59 
Snai2 
(Snail family transcriptional 
repressor 2) 
Fw: ACA CTG CTG CCA AAC CAT TTC 
Rev: TAG GCG TGG CTA TTA ACC GT 
56 
St8sia3 
(St8 alpha-N-acetyl-neuraminide 
alpha-2,8-sialyltransferase 3) 
Fw: TAA AGG TCC AGT TGG CTT GG 
Rev: CGT TTG GGT GAC AGG TGT TT 
55 
TBP 
(TATA-box Binding Protein) 
Fw: CAG GAG CCA AGA GTG AAG AAC AAT CC 
Rev: CTG GGA AGC CCA ACT TCT GC 
61 
Wnt11 
(Wingless-type MMTV integration 
site family, member 11) 
Fw: TGG AGC GAT GTC ACT GCA AG 
Rev: AGA TTT GGG GGC AGA TTG GG 
58 
Wnt6 
(Wingless-type MMTV integration 
site family, member 6) 
Fw: CGA GGA GAA CTG TCT GTG CC 
Rev: AGA CGC CTG ACA ACT AAG CC 
59 
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Table 3. 17. Master Mix used in genetic analysis by qPCR. Primers are the ones described in table 3.13 (Sigma 
Aldrich) and 2x SYBR® Master Mix is from Life Technologies GmbH. 
Reaction component Volume per reaction (µl) 
2x SYBR® Master 5 
Primer Fw (3 mM) 1 
Primer Rev (3 mM) 1 
Template cDNA 0.02 
Nuclease-free water Up to 10 
 
 
Table 3.18 describes the conditions used in amplification of the qPCR reactions of the 
analysed genes. 
 
Table 3. 18. Amplification conditions used for qPCR reactions. 
Temperature (ºC) Duration (min or sec) Number of cycles 
95 10 min  
95 15 sec 
40 
60 1 min 
95 15 sec  
60 1 min  
 
 
All samples were run in triplicates and results were treated using Livak’s 
normalization method. 
 
3.8.3. Statistical analysis 
Graphics and statistical analysis were done using GraphPad Prism® (version 6.0) 
software. Statistical differences were evaluated with Student’s t test.  
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4. RESULTS AND DISCUSSION 
In order to gain insight about the cell ablation system studied, morphological, cytometric 
and genetic approaches were used. Immunostaining was used to confirm the DT receptor 
expression and to assess apoptosis, while histological staining allowed to visualize the 
phenotype of the embryonic small intestine. Cytometric and genetic experiments were 
performed in order to obtain a more detailed insight into the genetic profile of some cell 
populations and also into the efficiency of the DT-mediated ablation system of Id2+ cells.  
 
4.1. Sampling 
To perform the studies presented in this work, collection of mouse embryos and isolation 
of their internal organs was required. The typical morphology of a whole mouse embryo at 
developmental stage E14.5, and its internal organs, is presented on Figure 4.1. 
 
 
Figure 4. 1. Mouse embryo at E14.5 (A) and its internal organs (B). The internal organs dissected included 
lungs (lu), liver (l), small intestine (si), stomach (st), as well as heart (h), large intestine (li), appendix (a) and 
kidney (not visible in the picture). Scale bars correspond to 2 mm. Pictures taken in Leica MF205 FA microscope. 
 
4.2. Establishment of the inducible system 
The iDTR ablation system consists in the expression of the DT receptor (HB-EGF, also 
known as iDTR) under the control of the specific promoter of a gene of interest, causing the 
death of the cells that express the receptor upon treatment with DT. This system was an 
important tool in this study given its versatility, since the system can be activated at the 
developmental stage of interest, and specificity for the target cells. Thus, we first investigated 
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the functional properties of the iDTR system in vivo by testing whether the expression of the 
DT receptor confers the small intestine’s cells the sensitivity to DT, resulting in their death. 
In order to do so, the mice strain chosen was HprtCreiDTR. In their genome, these mice 
harbour both the STOP cassette, which is flanked by two loxP sites, and the gene that encodes 
for iDTR under the control of a ubiquitous promoter. Therefore, after homologous 
recombination mediated by the Cre enzyme, all cells will express the DT receptor at their 
surface. 
 
Crossings to obtain HprtCreiDTR progeny were either performed with the male parent 
harbouring the Cre enzyme and the female the iDTR gene, or the other way around, in order to 
determine whether this would influence the results (Table 1). However, when the Cre enzyme 
was from the male parent no phenotypical differences were detected, between DT-sensitive and 
non-sensitive cells treated with DT, by H&E staining (data not shown). This lack of 
phenotypical differences observed in the first two crossing might have been related to the parent 
carrying the mutation for the Cre enzyme. Maternal or paternal transmission of this enzyme has 
some influence, since in some mouse strains the enzyme activity is stronger if its inherited from 
the mother127,128. 
  
Table 4. 1. Time points between TAM administration, DT injection and mouse dissection in HprtCre x iDTR 
crossings done along this project. 
  Time points  
Crossing TAM DT Dissection 
1. HprtCre male x iDTR 
female 
E13.5 E15.5 E16.5 
2. HprtCre male x iDTR 
female 
E13.5 E14.5 E15.5 
3. HprtCre female x 
iDTR male 
E9.5 Not treated E16.5 
4. HprtCre female x 
iDTR male 
E11.5 E13.5 E14.5 
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4.2.1. iDTR expression in HprtCreiDTR mice 
Before any further experiments, it was necessary to determine whether the DT 
receptor was being expressed in the in vivo system. For this purpose, protein lysates were 
prepared from liver cells collected from HprtCreiDTR mice previously genotyped for the 
presence of iDTR. Positive and negative samples were analysed by Western Blot targeting 
iDTR. (Figure 4.2). 
 
 
Figure 4. 2. Western Blot analysis of HprtCreiDTR mice liver protein lysates targeting for HB-EGF on a 
15% acrylamide SDS-PAGE transferred to a PVDF membrane. Samples were blotted with primary antibody 
Goat anti-Hbegf (1:2000) and secondary antibody Donkey anti-Goat IgG-HRP (1:3000). Lysates from negative 
and positive DT receptor mice are shown as iDTR- and iDTR+, respectively.  L corresponds to the ladder Color 
Prestaned Protein Standard, Broad Range (11-245 kDa) from New England BioLab® Inc. 
 
Results from the Western Blot on HB-EGF confirmed the genotyping results 
(Figure 4.2). However, a more intense band was detected around 23 kDa, along with several 
others with a molecular weight between 22 and 25 kDa, in the iDTR+ sample. Besides the 
membrane-anchored form of HB-EGF (DT receptor), the secreted form of the protein is also 
processed at multiple sites in the N-terminal portion, rendering the secretion of multiple forms 
of HB-EGF with different molecular weights129. Therefore, some of the bands observed by 
Western Blot may be related to these secreted forms, or are post-translational modified forms. 
The band detected with 11 kDa in all samples could be due to unspecific binding of the 
antibody. 
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These results indicate that the homologous recombination was successful, meaning 
that the STOP cassette was removed and, as a consequence, the gene that encodes the DT 
receptor was transcribed and the protein synthesized. 
 
4.2.2. Genotyping 
Once it was determined that the DT receptor was expressed in HprtCreiDTR mice, 
further experiments were conducted in this strain. Prior to these, litters were genotyped in order 
to choose the suitable embryos to carry on the work. The genotyping results from embryos 
treated with the toxin are shown in Figure 4.3. DT non-treated embryos were already genotyped 
(data not shown). 
 
 
Figure 4. 3. Genotyping results of HprtCreiDTR embryos treated with DT, for Hprt-Cre wt (200 bp), iDTR 
wt (650 bp), Hprt-Cre mut (120 bp) and iDTR mut (450 bp), on a 2% agarose gel in 1x TAE stained with 
ethidium bromide (EtBr). (-) and (+) are the negative and positive controls of the PCR reaction. wt – wildtype. 
mut – mutant. L corresponds to the ladder GeneRuler 1Kb Plus DNA Ladder. 
 
Genotyping for the wildtype form of the gene works as a positive control for the 
presence of DNA, since the presence of a band is expected for every embryo, allowing to 
perceive if there is DNA in the collected samples. 
According to these results, only 2 embryos (embryos 7 and 9) would have the DT 
receptor ubiquitously expressed, given the fact that they are the only two positive for the mutant 
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forms of Hprt-Cre and iDTR. Embryos 8 (iDTR-) and 9 (iDTR+) from the DT treated condition 
were used in further experiments. 
 
 
4.2.3. DT receptor localization and cell death assessment   
For a better assessment of the distribution of the DT receptor – iDTR – within the 
embryonic small intestine and determine if there was cell death upon DT treatment, 
immunostaining against HB-EGF and γH2AX was performed, respectively. In this assay, 4 
conditions were studied: embryos iDTR negative and positive, both treated with and without 
DT. DT- embryos were collected at E16.5 and DT+ at E14.5. The time points (Table 4.1) were: 
TAM at E9.5 for iDTR- embryos, and TAM at E11.5 and DT at E13.5 for iDTR+ embryos. This 
difference between the developmental stages will not have an impact on the results, since the 
assays performed with the HprtCreiDTR strain were just to evaluate if the system worked in 
mouse embryos. 
 
Samples were also counterstained with 4’, 6-diamidino-2-phenylindole (DAPI), a 
blue fluorescent dye, that binds strongly to adenine-thymine-rich regions, staining 
preferentially dsDNA and allowing the visualization of nucleus morphology and apoptosis130. 
 
Immunostaining against the DT receptor (HB-EGF) is shown in Figure 4.4. No 
fluorescence is detected on iDTR- embryos (Figure 4.4 A and E), meaning that the receptor is 
not expressed in these conditions, as expected. iDTR+ embryos show fluorescence all over the 
small intestine section (Figure 4.4 I and L), due to the ubiquitous expression of the receptor in 
this strain.  
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Figure 4. 4. Immunostaining against HB-EGF in 10 µm cryosections from HprtCreiDTR mouse embryos. 
HB-EGF (magenta) and DAPI (blue) stainings are presented in the first and second columns (from left to right), 
respectively. Bright-field (BF) images are shown in the third column and merge of all the pictures on the last one. 
Scale bars correspond to 10 µm. 
 
To assess cell death within the embryonic small intestine in the 4 different 
conditions, samples were stained against γH2AX (Figure 4.5). Once cells are exposed to DNA-
damaging agents, like radiation or genotoxic compounds, histone H2A variant H2AX will be 
phosphorylated into γH2AX due to the appearance of double-stranded breaks. This staining is 
sensitive for the analysis of DNA damage due to the fast and abundant phosphorylation of 
H2AX, as well as its correlation with each double-stranded break131,132. 
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Figure 4. 5. Immunostaining against γH2AX in 10 µm cryosections from HprtCreiDTR mouse embryos. 
γH2AX (green) and DAPI (blue) stainings are presented in the first and second columns (from left to right), 
respectively. The white arrow indicates the apoptotic sites. Bright-field (BF) images are shown in the third column 
and merge of all the pictures on the last one. Scale bars correspond to 10 µm. 
 
Apoptosis was not detected in iDTR- negative embryos – DT- and DT+ (Figure 4.5, A 
and E, respectively) –, as expected. The sample positive for the DT receptor (Figure 4.5, L) 
presents some apoptotic sites at the small intestine’s lumen (white arrow), evidencing the action 
of the toxin in the DT-sensitive cells. However, some residual fluorescence is also observed in 
the iDTR+DT- embryo (Figure 4.5, I), but it is most likely due to auto-fluorescence.  
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4.2.4. Embryo morphology 
In order to see how DT affects the morphology of the embryo, hematoxylin and eosin 
staining was performed on sections (Figures 4.6 and 4.7). Besides the small intestine, the 
morphology of the lungs is also shown (third line in both figures), since these two organs share 
a similar tissue composition – epithelium and mesenchyme. 
 
Figure 4. 6. Histology of small intestine and lungs from mouse embryos at E16.5 non-treated with DT. 10 
µm cryosections were stained with hematoxylin and eosin.  Embryo DT receptor negative (iDTR-) is shown on the 
left panel and the positive (iDTR+) on the right. Images A-D and G-J show the small intestine; E-F and K-L show 
the lungs. At this stage, the small intestine presents a more complex structure: e – epithelium, iv – inter-villus 
region, l – lumen, m – mesenchyme, v - villi. Scale bars on A, C, E, G, I and K are 100 µm; on B, D, F, H, J and 
L are 50 µm. 
 
Comparing both embryos (iDTR- and iDTR+) without the DT treatment, both showed a 
normal development for this embryonic stage. At E16.5 villi are already fully developed and 
these structures can be seen, together with the inter-villus regions, on Figure 4.6 B. 
The lungs also present a normal morphology for this developmental stage. 
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Figure 4. 7. Histology of small intestine and lungs from HprtCreiDTR mouse embryos at E14.5 treated with 
DT. 10 µm cryosections were stained with hematoxylin and eosin. Embryo DT receptor negative (iDTR-) is shown 
on the left panel and the positive (iDTR+) on the right. Images A-D and G-J show the small intestine; E-F and K-
L show the lungs. At this stage, the small intestine presents a more complex structure: e – epithelium, l – lumen, 
m – mesenchyme. Black arrows indicate the detachment between the epithelium and the mesenchyme. Scale bars 
on A, C, E, G, I and K are 100 µm; on B, D, F, H, J and L are 50 µm. 
 
Embryos treated with DT showed a different scenario. While the small intestine of 
iDTR- embryos presents a morphology similar to those of the control embryos portrayed in 
Figure 4.6, the small intestine of iDTR+ embryo shows drastic changes in its phenotype (Figure 
4.7, G-L). The most prominent feature in this condition is the detachment between the 
epithelium and the mesenchyme (indicated by black arrows), observable not only on the small 
intestine (Figure 4.7, H and J) but also in the lungs (Figure 4.7, L). Interestingly, a population 
of distinct cells is visible on the histological sections of DT receptor positive embryo exposed 
to the toxin (Figure 4.8). These cells are likely to be white blood cells, since DT is able to 
penetrate the cells that express the receptor, causing an inflammatory response, and as a 
consequence, the organism activates its defence mechanisms against the toxin. 
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Figure 4. 8. Histology detail of small intestine from HprtCreiDTR mouse embryos at E14.5 treated with DT. 
Black arrows indicate what could be white blood cells. B is the augmentation of the zone inside the box in A. Scale 
bars are 200 µm and 100 µm in A and B, respectively. 
 
These assays allowed to conclude about the global efficiency of the system, using a 
generic mouse strain. Based on the immunostaining results, the DT receptor was only expressed 
in iDTR+ mice and apoptosis was detected only in mice that expressed the receptor and were 
treated with the toxin.  
Histological analysis showed that both embryos not treated with DT (iDTR- and 
iDTR+) and the iDTR- embryo treated with DT had the same phenotype. These results indicate 
that 1) neither the receptor nor the toxin are harmful to the embryo by themselves and 2) the 
apoptosis and phenotype observed in the iDTR+ embryo treated with DT is due to the interaction 
between the toxin and the receptor. 
 
 
4.3.Ablation of Id2 positive cells 
4.3.1. Establishment of conditions 
As mentioned in section 2, the main goal of this project was the ablation of Id2+ cells 
and the study of its consequences within the embryonic small intestine. The mice strain used 
was Id2CreiDTR (Annex 1), where only cells that are Id2 positive will express the DT receptor 
at their surface, thus being the only cells sensitive to the toxin’s action. 
 
The evaluation of the expression of the receptor and cell death focuses within the 
embryonic small intestine at E14.5 is shown in Figures 4.9 and 4.10, respectively. Embryos 
used in this assay were previously genotyped (data not shown), and Id2+iDTR+ embryos – 
treated and untreated with DT – were used. During the analysis of the slides by fluorescence 
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microscopy, it was observed that the receptor was mostly expressed in the anterior section of 
the embryonic small intestine compared the posterior section, being this differences portrayed 
in the Figure 4.9. The anterior section of the small intestine corresponds to the portion that 
goes from the beginning of the gut tube until the middle, and the posterior section to the 
remaining portion, right before the appendix (Annex 2). Morphologically, the anterior section 
of the embryonic small intestine is larger than the posterior, and the latter presents a more 
roundish shape, as seen in the figure below. 
 
 
Figure 4. 9. Immunostaining against HB-EGF in 10 µm sections from Id2CreiDTR mouse embryos at E14.5, 
embedded in paraffin. Expression of the DT receptor in the different sections of the embryonic small intestine – 
anterior and posterior – is shown. Female mouse was treated with TAM at E11.5 and DT at E13.5. Bright-field 
(BF) images are shown in second column and the merge of all the pictures in the last one. Scale bars correspond 
to 10 µm. 
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The figure above shows fluorescence in the epithelium of the embryonic small 
intestine, indicating that the DT receptor is being expressed in this strain, independently of the 
DT treatment. Russell et al. (2004) described that Id2 is expressed in the epithelial cells during 
the embryonic development of the small intestine, but not in the mesenchyme121,133. Even 
though there are some fluorescent zones in the mesenchyme in Figure 4.9 A – maybe due to 
unspecific binding –, most of the cells expressing Id2 are localized in the small intestine’s 
epithelium, as stated in the literature.  
The fact that Id2+ cells expressing the receptor are only visible in the anterior section 
of the small intestine (Figure 4.9 A and G), might indicate that Id2 is mostly expressed on the 
anterior portion of the embryonic small intestine. There is also an observable difference 
between the number of cells expressing the DT in the anterior sections. In Figure 4.9 G, there 
is less expression of the DT receptor detected compared to Figure 4.9 A, possibly due the fact 
that this embryo was treated with DT and, as consequence, cell death occurred. 
Regarding the posterior portion (Figure 4.9 D and J), the receptor was not detected, 
even though what appears to be auto-fluorescence was. 
 
 
Figure 4. 10. Immunostaining against γH2AX in 10 µm sections from Id2CreiDTR mouse embryos at E14.5 
embedded in paraffin. Female mouse was treated with TAM at E11.5 and DT at 13.5. Bright-field (BF) images 
are shown in second column and the merge of all the pictures in the last one. Scale bars correspond to 10 µm. 
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Once the receptor was detected, it was important to verify if the toxin could cause cell 
death in the samples expressing the DT receptor. Regarding cell death, only auto-fluorescence 
was detected (Figure 4.10 A and E), meaning that a 2-day interval between the treatments 
with TAM and DT is not enough to induce apoptosis. These results are supported by the 
embryonic small intestine’s morphology portrayed in Figure 4.11, where no phenotypic 
changes can be observed between both conditions.  
 
 
Figure 4. 11. Histology of small intestine and lungs in 10 µm sections from Id2CreiDTR mouse embryos at 
E14.5, treated and not treated with DT, embedded in paraffin. Sections were stained with hematoxylin and 
eosin. Female mouse was treated with TAM at E11.5 and DT at 13.5. Scale bars correspond to 50 µm. 
 
 Given the previous results, and in order to assess if the time interval had an effect in 
the toxin’s action, the assays were repeated but the time point between TAM and DT 
administration was increased to 5 days. Embryos were genotyped and a double negative (iDTR-
DT-) and a double positive (iDTR+DT+) embryo were taken for further experiments. 
Immunostaining and morphology assays are shown in Figures 4.12 to 4.14. 
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Figure 4. 12. Immunostaining against HB-EGF in 10 µm sections from Id2CreiDTR mouse embryos at E15.5 
embedded in paraffin. Female mouse was treated with TAM at E8.5 and DT at E13.5. A and B are an overview 
of the embryonic small intestine section. The remaining pictures present the anterior portion of the embryonic 
small intestine. Bright-field (BF) images are shown in second column and the merge of all the pictures in the last 
one. a – anterior. p – posterior. Scale bars correspond to 50 µm in A and E, and 20 µm in the remaining pictures.  
 
Similar to what is described in Figure 4.9, fluorescence correspondent to the receptor 
expression is mainly observed in the anterior part of the small intestine (Figure 4.12 B). The 
presence of the DT receptor in the sections from the embryonic small intestine was only 
detected in samples genotyped positively for iDTR (Figure 4.12 B and F), with dispersed 
fluorescent zones visible in the epithelium. This scattered fluorescent can be related to the 
efficiency of the homologous recombination induced by TAM so, even though the embryo is 
iDTR+, not all the epithelial cells could be expressing the DT receptor. Also, since this assay 
was performed after the treatment with the toxin, it’s expected to be less signal since some cells 
may have died. 
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Figure 4. 13. Immunostaining against γH2AX in 10 µm sections from Id2CreiDTR mouse embryos at E15.5 
embedded in paraffin. Female mouse was treated with TAM at E8.5 and DT at E13.5. The white arrow indicates 
the apoptotic zone. Bright-field (BF) images are shown in second column and the merge of all the pictures in the 
last one. Scale bars correspond to 10 µm. 
 
 Apoptotic zones were detected in the small intestine’s lumen (Figure 4.13) by 
immunostaining against γH2AX, indicating that with 5 days between the treatment with TAM 
and DT some cells start to undergo the apoptotic process. 
  
 
Figure 4. 14. Comparison between the histology of small intestine in 10 µm cryosections from (A-B) 
HprtCreiDTR mouse embryos at E14.5 and (C-D) Id2CreiDTR mouse embryos at E15.5 embedded in paraffin, 
treated with DT. (A-B) Female mouse was treated with TAM at E11.5 and DT at E13.5. (C-D) Female mouse 
was treated with TAM at E8.5 and DT at E13.5. Posterior (A) and anterior portions (B and D) of embryonic the 
small intestine are portrayed. Both portions are presented in C. Prominent characteristics, such as areas of 
detachment and lumen enlargement, are indicated by the black arrows. Scale bars correspond to 50 µm in A and 
B, 200 µm in C and 100 µm in D. 
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 The phenotype of Id2CreiDTR mouse embryos treated with DT is presented in Figure 
4.14. The morphology of the Id2+iDTR+ embryos was compared with iDTR+ treated with DT 
from the HprtCreiDTR litter, used as a negative control. Even though the phenotype is not as 
drastic as the observed in HprtCreiDTR embyros upon DT treatment, Id2CreiDTR embryos 
present a detachment between the small intestine’s epithelium and the mesenchyme (indicated 
by the arrows in Figure 4.14 D). The lumens size also appears to have increased (indicated by 
the arrows in Figure 4.14 C). All this features are not present in Figure 4.14 A and B, where a 
normal morphology of the embryonic small intestine is presented. 
 
 Compared with the first assays performed with Id2CreiDTR embryos, these results 
indicate that the labelling of Id2+ cells is efficient at E8.5. The modifications observed by DT 
action might be due to the increase of time between its injection and the collection of the 
embryos, giving the toxin more time to take action. 
 However, immunostaining - together with fluorescence microscopy – is a detection 
method with low efficiency. The percentage of labelled cells detected is very low – 
approximately 10% – and these results are influenced by the time gap between the TAM 
administration and mouse opening. Due to this, by the time this assay is done it’s not the Id2+ 
progenitor cells that are labelled, but its descendants.   
 
4.3.2. Isolation of intestinal epithelial cells 
In order to overcome the limitations of immunostaining and gain more insight on the 
DT-mediated ablation of Id2+ cells, further work was conducted using a new strain: 
Id2CredsRed+/-Lgr5GFPiDTR mice (Annex 3). Besides the histochemical analysis, this system 
allowed to measure the percentage of Id2+ cells, since they would show red fluorescence, giving 
a more precise idea of the efficiency of the method used to ablate the Id2+ cells – besides the 
DT receptor, some Id2 positive mouse embryos will also express dsRed, which encoded for a 
red fluorescent protein. 
  
 Immunostainings to assess the expression of the receptor and apoptosis in this new 
strain are shown in Figure 4.15. 
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Figure 4. 15. Immunostaining against HB-EGF and γH2AX in 10 µm cryosections from Id2CredsRed+/-
Lgr5GFPiDTR mouse embryos, treated with DT, at E13.5. Female mouse was treated with TAM at E8.5 and 
DT at E12.5. (A to H) Immunostaining against HB-EGF. (I to P) Immunostaining against γH2AX. Apoptotic sites 
are indicated by the white arrows. Bright-field (BF) images are shown in the third column and merge of all the 
pictures on the last one. Scale bars correspond to 10 µm. 
  
 These stainings show the expression of the DT receptor in the epithelium of the Id2+ 
iDTR+ embryo (Figure 4.15 E), as well as apoptosis in the small intestine’s lumen in the same 
conditions (Figure 4.15 M). Receptor is not expressed in the double negative sample and, 
regarding the staning against γH2AX, only auto fluorescence was detected (Figure 4.15 A and 
I, respectively).  
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Once the receptor’s expression and apoptosis were detected in this strain, work 
progressed to the isolation of intestinal epithelial cells.  
To do so, and besides the embryonic small intestine, lungs were collected. This organ 
was observed under a microscope to detect red fluorescence, given the fact that if the embryo 
is positive for dsRed, lungs will present red fluorescence (Figure 4.16). This method allows the 
rapid selection of the embryos that should undergo sorting. After sorting, embryos were 
genotyped in order to determine which ones were expressing the receptor and which of the 
embryos presenting red fluorescence on the lungs were positive for Id2 and dsRed. (Figure 
4.17). 
 
 
 
Figure 4. 16. Red fluorescence detected in lungs from Id2CredsRed+/-Lgr5GFPiDTR mouse embryos, treated 
with DT, at E14.5. Pictures show lungs from an embryo negative (A-C) and positive (D-F) for dsRed. BF – bright 
field. Pictures taken in a Leica IL LED microscope. Scale bar corresponds to 10 µm. 
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Figure 4. 17. Genotyping results of Id2CredsRed+/-iDTR embryos treated with DT, for iDTR mut (450 bp), 
Id2 mut (650 bp) and dsRed (190 bp), on a 2% agarose gel in 1x TAE stained with EtBr.  (-) and (+) are the 
negative and positive controls of the PCR reaction. mut – mutant. L corresponds to the ladder GeneRuler 1Kb Plus 
DNA Ladder. 
 
 From 16 embryos, 7 were double positive (Id2+iDTR+) but only 3 were triple positive 
(Id2+iDTR+dsRed+) – embryos 3, 10 and 13. 
 
 Intestinal epithelial cells from mouse embryos were isolated by FACS. In order to 
isolate the target cells, samples were stained with EpCam antibody, given the fact that this 
protein is present in the intestinal epithelium. Cells were co-stained with DAPI to discriminate 
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between live and dead cells. Only cells positive for EpCam were gated to be analyzed for red 
fluorescence by flow cytometry (Figure 4.18).  
 
 
Figure 4. 18. Strategy used in the isolation of epithelial intestinal cells. Cells were co-stained with DAPI in 
order to discriminate between living and dead cells (A). Duplets were discarded and only single cells were taken 
for further analysis (B). Through EpCam staining, single cells were divided into epithelial cells (EpCam+, right 
gate) and mesenchymal cells (EpCam-, left gate) (C). Finally, EpCam+ cells were sorted for red fluorescence. Non-
red (P3), red (P6) and high-red EpCam+ cells (P5) (D). 
 
In this conditions – 2-day interval between the administration of TAM and DT, and 
dissection a day after toxin administration – only one (embryo 10) out of the 3 triple positive 
embryos showed a decrease in the red cells percentage (Figure 4.19). Non-red and high-red 
EpCam+ cells from the triple positive (embryo 10) and from an Id2+iDTR-dsRed+ sample 
(embryo 8) were collected for further genetic analysis by qPCR. 
 
 
Figure 4. 19. Red epithelial cells from embryonic small intestine sorted at E13.5. (A) Id2+iDTR-dsRed+ 
embryo. (B) Id2+dsRed+iDTR+ embryo. P3 – Non-red epithelial cells. P4 – Red epithelial cells. P5 – High-red 
epithelial cells. 
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The percentage of epithelial red cells on the iDTR- sample (Figure 4.19 A) was 
65.5%, while on the triple positive (Figure 4.19 B) was 36.6% – approximately 30% less.  
 
As mentioned above, only 1 out of 3 triple positive embryos showed a decrease in the 
red cells percentage. To see if both the percentage of labeled and ablated cells would increase, 
a new experimental setup was established – labeling with TAM was done at E7.5 and DT was 
injected during 3 consecutive days (E8.5 to E11.5). Dissection was done 3 days after the last 
toxin injection (E14.5).  
However, in this litter, 7 out of 13 embryos were not alive at the time of the collection. 
Furthermore, according to genotyping results (Figure 4.20), the DT-sensitive embryos were 
among the dead pups, so only iDTR- samples were taken for cell sorting (Figure 4.21).  
 
 
Figure 4. 20. Genotyping results of Id2CredsRed+/-iDTR embryos treated with DT, for iDTR wt (650 bp), 
iDTR mut (450 bp) and Id2 mut (650 bp), on a 2% agarose gel in 1x TAE stained with EtBr. Embryos 1 to 7 
were dead inside the mother’s womb at the time of the collection. (-) and (+) are the negative and positive controls 
of the PCR reaction. wt – wildtype. mut – mutant. L corresponds to the ladder GeneRuler 1Kb Plus DNA Ladder. 
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Figure 4. 21: Red epithelial cells from embryonic small intestine sorted at E14.5. (A) Id2-iDTR-dsRed- 
embryo. (B) Id2+dsRed+iDTR- embryo. P3 – Non-red epithelial cells. P4 – Red epithelial cells. P5 – High-red 
epithelial cells. 
 
As expected, no red cells were detected by FACS in the negative sample (Figure 4.21 
A), which was in accordance with the genotyping results that had identified this sample as Id2 
negative and thus it did not have the dsRed cassette on its genome. On the sample positive for 
Id2 and dsRed, only 1% of the analyzed cells were red (Figure 4.21 B), suggesting that the 
homologous recombination was not efficient. 
Even though Danielian et al. (1998) reported that a single injection of 2 mg of TAM 
– similar to the dose administrated – at E8.5 led to a rapid loss of embryos134, TAM was not the 
cause of death of the embryos, since it only occurred in iDTR+ embryos. This means that the 
three consecutive DT injections were most likely the cause of death of 53% of the litter. The 
lethality could be due to 1) the toxin’s action itself, given its toxicity or 2) since Id2 is expressed 
in other tissues than the epithelium of the small intestine during embryonic development – thus 
the DT receptor will be expressed in those other tissues as well –, the consecutive treatment 
with DT might have ablate Id2+ cells at a larger scale, and taken together, it caused the 
inviability of the iDTR+ embryos. 
 
Due to the previous results, in the third crossing that was carried out to produce 
Id2CredsRed+/-Lgr5GFPiDTR progeny, TAM was administrated at a later time point – E11.5. 
Thus, DT was injected at E13.5 and dissection performed 3 days later, at E16.5. Embryo 
genotyping results are showed in Figure 4.22. To note that all the embryos were viable at the 
time of collection. 
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Figure 4. 22. Genotyping of Id2CredsRed+/-Lgr5GFPiDTR embryos treated with DT, for dsRed (190bp), Id2 
mut (650 bp) and iDTR mut (450 bp), on a 2% agarose gel in 1x TAE stained with EtBr. (-) and (+) are the 
negative and positive controls of the PCR reaction. mut – mutant. L corresponds to the ladder GeneRuler 1Kb Plus 
DNA Ladder. 
 
The embryos were dissected, the small intestines collected and divided in anterior 
and posterior (Annex 2). Epithelial cells of each of the sections of the embryonic small intestine 
were isolated and samples were sorted for red cells (Figure 4.23). 
 
 
Figure 4. 23. Sorted red epithelial cells from small intestine of mouse embryos at E16.5. (A) Id2-iDTR-dsRed- 
embryo (triple negative). (B) and (C) Id2+dsRed-iDTR+ embryo (double positive). P3 – Non-red epithelial cells. 
Red – Red epithelial cells. P5 – High-red epithelial cells. 
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According to genotyping (Figure 4.22), none of the embryos were triple positive 
(Id2+iDTR+dsRed+), since none of them presented the bands for all the 3 gene fragments 
analyzed. These results were further confirmed by FACS, where no red cells were detected 
(Figure 4.23). 
Besides the red fluorescence, the strain used in these assays – Id2CredsRed+/-
Lgr5GFPiDTR – has a gene that encodes for the green fluorescent protein (GFP) under the 
control of the Lgr5 gene promoter. Due to this, if an embryo is positive for Lgr5, it will present 
green fluorescence. Sorting showed changes in the green cell percentage and, given this, they 
were analyzed to verify if the DT in DT-sensitive embryos would have any effect in this green 
cell population. A representation of the gates used to assess the percentage of green cells is 
shown in Figure 4.24. 
 
 
Figure 4. 24. Sorted green epithelial cells from small intestine of mouse embryos at E16.5. (A) Cells from 
gate P9, non-red epithelial cells, were sorted and analysed for green fluorescence (GFP). (B) Lgr5- embryo. (C) 
Id2+Lgr5+iDTR+. (D) Id2+Lgr5+iDTR- embryo.  
 
 The effect of Id2+ cell ablation in the Lgr5+ cell population can already be observed 
in Figure 4.24, where the iDTR+ embryo has less green cells than the iDTR- (Figure 4.24, C 
and D, respectively). To have a better understanding of the influence of the Id2 ablation in the 
green cell population, percentages between iDTR- and iDTR+ embryos, both for the anterior 
and posterior portions of the embryonic small intestine, were compared (Figure 4.25). 
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Figure 4. 25. Green cell percentage in Lgr5 positive mouse embryos collected at E16.5 obtained by FACS 
analysis of different sections – anterior and posterior – of the small intestine.  
 
The cells from the posterior section of the embryonic small intestine express more 
Lgr5, as higher percentages of green cells were found in the cell preparation from this section 
when compared with the values observed from the anterior embryonic small intestine (Figure 
4.25). The Id2+iDTR+ embryo showed a green cell percentage of 5.3% and 9.2% - in anterior 
and posterior, respectively – against the 7.7% and 13.1% presented by Id2-iDTR+. In double 
negative samples (embryos 3, 4, 6, 9), the green cells percentages range from 4.1% to 6.9% in 
anterior and from 10.6% to 19.1% in the posterior embryonic small intestine. These results 
show that the green cell percentages presented by Id2+iDTR- embryos are within the range of 
the negative controls and so, the difference in the Lgr5+ cell population observed in Id2+iDTR+ 
is due to the toxin’s action. This evidences the existence of a possible correlation between the 
Id2+ and Lgr5+ cells, even though it was not possible to detect changes in the red Id2+ cell 
population, and compare the changes between both populations. 
 
In order to have stronger red cell signal, further crossings were done with one of the 
parents being homozygous for dsRed (dsRed+/+). Also, this litter had a three-day break between 
TAM (E11.5) and DT (E14.5) treatments. Embryos were collected at E15.5. Genotyping was 
performed in the collected embryos and results are shown in Figure 4.26. The gates used for 
sorting of the red cells are the ones described previously in Figure 4.18. 
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Figure 4. 26. Genotyping of Id2CredsRed+/+Lgr5GFPiDTR embryos treated with DT, for Id2 wt (370 bp), Id2 
mut (650 bp) and iDTR mut (450 bp), on a 2% agarose gel in 1x TAE stained with EtBr. (-) and (+) are the 
negative and positive controls of the PCR reaction. wt – wildtype. mut – mutant. L corresponds to the ladder 
GeneRuler 1Kb Plus DNA Ladder. 
 
Genotyping results (Figure 4.26) show that only two out of 11 embryos were double 
positive for Id2 and iDTR (embryos 4 and 11), since just this 2 present bands for the mutant 
form of Id2 and iDTR. All of the mouse embryos collected were analyzed by FACS to detect 
the presence of red fluorescent cells (Id2+ cells) and embryos 1 to 4, as well as 11, were positive 
for red fluorescence. However, only 1, 3, 4 and 11 were positive for Id2 mut. This means that, 
between these 4 embryos, theoretically only embryos 4 and 11 will show a decrease in the Id2 
red cell population due to the action of DT. 
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Figure 4. 27. Red Id2+ cells percentage in mouse embryos collected at E15.5 obtained by FACS analysis of 
different sections – anterior and posterior – of the small intestine. 
 
 Overall, the posterior part of the embryonic small intestine shows less percentage of 
Id2+ red cells (Figure 4.27), indicating that Id2 can be more expressed in the anterior section. 
However, the embryo that shows less percentage of red cells both in anterior and posterior 
section of the small intestine – embryo 3 – is only positive for Id2 mut, meaning that the Id2+ 
cell ablation mediated by the toxin was not successful in this assay. This is further supported 
by the fact that both Id2+iDTR+ embryos – 4 and 11 – presented about the same red cell 
percentages as the embryos that don’t express the DT receptor.  
 
 The percentage of Lgr5+ green cells in the different embryo’s small intestine sections 
(anterior and posterior) was also analyzed by FACS and are shown in Figure 4.28. 
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Figure 4. 28. Green cell percentage in Lgr5 positive mouse embryos collected at E15.5 obtained by FACS 
analysis of different sections – anterior and posterior – of the small intestine. 
  
 Similarly, to what was observed on Figure 4.25, cells expressing Lgr5 were found to be 
expressed in higher amount in the posterior section of the embryonic small intestine in this litter 
(Figure 4.28). Also, iDTR+ embryos show less green cells in the posterior section when 
compared to embryo 3, which is iDTR-, evidencing once more the possible influence of Id2 in 
the Lgr5+ population. 
 
 Since the intervals between the treatment with TAM and DT might influence the number 
of labeled and ablated cells, the time points should ideally be as close as possible. Due to this, 
and following the previous results, the interval between TAM and DT treatment was shortened 
to one day – TAM was administrated at E13.5, DT injected at E14.5 and dissection of the 
pregnant females performed at E16.5. Embryo genotyping, red Id2+ cell and green Lgr5+ cell 
percentages by FACS are shown in Figures 4.29 to 4.31, respectively. 
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Figure 4. 29. Genotyping of Id2CredsRed+/+Lgr5GFPiDTR embryos treated with DT, for Id2 wt (370 bp), Id2 
mut (650 bp) and iDTR mut (450 bp), on a 2% agarose gel in 1x TAE stained with EtBr. (-) and (+) are the 
negative and positive controls of the PCR reaction. wt – wildtype. mut – mutant. L corresponds to the ladder 
GeneRuler 1Kb Plus DNA Ladder. 
 
 According to genotyping, one out of 13 embryos is double positive for Id2 and iDTR 
(embryo 7). Embryos 2 and 9 are positive for Id2 and embryo 12 was positive only for iDTR. 
 
 
Figure 4. 30.  Red Id2+ cells percentage in mouse embryos collected at E16.5 obtained by FACS analysis of 
different sections – anterior and posterior – of the small intestine. 
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 Analyzing the FACS results for the Id2+ red fluorescent cells (Figure 4.30), it is possible 
to observe that one-day interval between TAM and DT treatment led to a decrease in the red 
cell percentage on the embryonic small intestine’s epithelium in the Id2+iDTR+ (embryo 7), 
when compared with the double negative (embryo 6), indicating that in this conditions the 
embryos were susceptible to the DT’s action. Embryos found to be iDTR+ (embryos 10 and 12) 
also show a lower amount of red cells, given the fact that these embryos have the DT receptor 
being expressed. Regarding embryo 10, the percentages observed – 0.5% in anterior and 1.8% 
in posterior – have a great difference compared to embryo 12. Given the fact that in this 
progeny, upon homologous recombination, the gene that encodes for dsRed is under the control 
of the Id2 specific promoter, it was expected that only Id2+ cells presented red fluorescence. 
Given this, either the red cell percentages of embryo 10 are an artifact caused by some dsRed 
leakage or this embryo is also Id2+. However, this cannot be inferred since when the genotyping 
for Id2 mut was done (Figure 4.29), embryo 10 had no band for Id2 wt, meaning that no genetic 
material was amplified possible due to insufficient DNA amount, even though when the 
genotyping for iDTR was performed it showed a band in the Id2 wt controls. 
 
 
Figure 4. 31. Green cell percentage in Lgr5 positive mouse embryos collected at E16.5 obtained by FACS 
analysis of different sections – anterior and posterior – of the small intestine. Embryo 3 is indicated with (*) 
because genotyping was inconclusive.  
  
As with the previous litters, Lgr5+ green cells were analyzed by FACS and the results 
are presented in Figure 4.31. Overall, with exception of embryo 13, there are more green Lgr5+ 
cells on the posterior section of the embryonic small intestine. However, even though the 
Id2+iDTR+ embryo (embryo 7) shows less green cells compared with most of the double 
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negatives (embryos 2, 3, 4, 6 and 13), the values are very similar to the ones presented in the 
iDTR- negative embryo, and thus no conclusions can be drawn. 
  
 As mentioned previously the time points between TAM administration, DT injection 
and embryo collection should be as close as possible, such as one day between each one, with 
special attention to the gap between TAM and DT – the bigger the interval, higher is the chance 
to label Id2+ descendants and not its progenitors. Although it’s reported in the literature that 
significant recombination is still observable between 24 and 48 h after TAM administration135, 
Robinson et al. (1991) stated that TAM peak levels occurred between 3 and 6 h after oral 
administration136. These authors also reported that the half-life of TAM in mice is 11.9 h136, 
which means that TAM levels at this organism are null roughly 24 h later its administration. 
However, the establishment of this ideal time points was not achieved during the 
execution of this project, since some of the female mice got abortions. From 9 Id2CredsRed+/-
Lgr5GFP x iDTR crossings, 3 of the females had an abortion the day after DT was injected. 
Although the abortions happened after the injection of toxin, the remaining mice treated in the 
same conditions had no complications to achieve the desired gestational stage, so these 
occurrences might be due to the antiestrogen activity of TAM. Similar events were reported by 
Danielian et al. (1998)134, where pregnancies failed shortly after TAM injection, even though 
this was stated to happen after three consecutive TAM administrations. 
 
4.3.2.1. Genetic analysis of intestinal epithelial cells 
We evaluated the genetic differences between Id2+ high-red intestinal epithelial 
cells between both conditions – DT receptor negative and positive – in order to assess the 
influence of the DT-mediated ablation in the cells genetic programs. Genetic analysis was 
conducted in embryonic small intestine collected at E13.5 from embryos treated with TAM at 
E10.5 and DT at E12.5.  
The following genes were analyzed: Id1, Id2, Id3, Lgr5, Wnt6, Wnt11, PUMA, 
Rspo1, Rspo3, Snai2, Smoc2, Sfrp5, Kcnq1, TPB, Kcne3, St8sia3, Slc2a3, OneCut. EpCam was 
used as the housekeeping gene, since it is constitutively being expressed in the embryonic small 
intestine epithelium. Results are shown in Figures 4.32 and 4.33. 
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Figure 4. 32. Gene expression analysis of Id2 and PUMA in high-red intestinal epithelial cells collected at 
E13.5. Results are shown as mean ± SEM, with N=3. Statistical significance was evaluated with Student's t test. 
*** corresponds to p<0.0001. 
 
Results of gene expression presented in figure 4.32 show a reduction in Id2 
expression levels in the red cells isolated from the iDTR+ mouse embryos, even though not 
statistically significant. These results might be due to the fact that ablation of Id2+ cells was not 
completely achieved. It is important to note the increase in PUMA expression – an apoptotic 
marker137 – in these cells expressing the DT receptor, thus  induced to die after the treatment 
with DT. Protein synthesis inhibition caused by the toxin’s penetrance into the cells iDTR+ will 
activate a p53-dependent apoptosis, in which PUMA is a key mediator137,138. 
During FACS only living cells (DAPI+) were collected for further analysis and there 
were still 36.6% of high-red cells detected in the embryos treated with DT (Figure 4.19 B). 
Together with the fact that Id2 expression level in the epithelial cells treated with DT is not 
null, this could mean that the cells analyzed by qPCR are the descendants of Id2+ cells initially 
labeled, that survived the DT-mediated ablation.  
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Figure 4. 33. Gene expression analysis of (A) Lgr5, Ascl2, Wnt11, Wtn6, Sfrp5, Rspo1, Snai2, Smoc2, (B) Id1, 
Id3, Kcnq1, TBP, Kcne3, St8sia3, Slc2a3, OneCut and Rspo3 in high-red intestinal epithelial cells collected 
at E13.5. Results are shown as mean ± SEM, with N=3. Statistical significance was evaluated with Student's t test. 
** corresponds to p<0.001 and *** to p<0.0001. 
  
 Besides PUMA, the following genes also showed statistical differences between 
both conditions: Ascl2, Wnt6, Wnt11, Sfrp5, Rspo1, Snai2, Smoc2 (Figure 4.33 A) Id1, Kcnq1, 
TBP and Rspo3 (Figure 4.33 B).  
 Ascl2 – a a basic HLH transcription factor that binds do the Lgr5 promoter139 – and 
Lgr5 showed opposite expression tendencies – an unexpected behaviour since they are both 
ISC markers. A similar finding was described by Mustata et al. (2013) when analyzing the 
genetic profile of organoids and spheroids140, which requires further analysis. Even though the 
principal driver of Ascl2 expression is the presence of Wnt/Rspo1 signalling141 (and both are 
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upregulated in high-red epithelial iDTR+ cells), there could be two reasons for the opposite 
behaviour of Lgr5 regarding Ascl2. Either 1) Lgr5 is being expressed but not transcript, which 
would require further analysis by Western Blot, or 2) since in wt conditions, Lgr5 only starts to 
be expressed at E13.5 (the same day when the analysed cells were collect) – it could be that 
other proteins that play a role in its transcription are still not active, and thus, do not potentiate 
a more significant expression of this gene. 
 
 Genes involved in cell proliferation – Wnt6 and Wnt11 – are upregulated in the cells 
expressing the DT receptor. Wnt11 was shown to be involved in cell proliferation and migration 
in the mouse intestinal cell line IEC654 and Wnt6 is one of the major Wnt ligands expressed in 
the small intestine142. Rspo1 and Rspo3, known Wnt agonists, are also overexpressed in the 
iDTR+ condition. As stated before, it could be that the analyzed cells are Id2+ labeled cells 
descendants, and thus their proliferative character, in order to reverse the cell loss. On the other 
hand, Sfrp5 – a Wnt antagonist, this is, it interferes with Wnts in a negative manner – has an 
inverse expression profile compared with the Wnt genes analyzed, emphasizing the 
proliferative character of these cells. 
  
 Regarding stemness, genes associated with this property are also overexpressed in 
high-red epithelial iDTR+ cells, namely Smoc2, an instestinal stem cell marker18,143, and Snai2. 
In adult mice, Smoc2 expression by ISC was reported by Muñoz et al. (2012) to be a probable 
physiological way to block BMP signaling in the stem cell niche143.  Snai2, also known as Slug, 
is a Snail family member reported to promote cells to adopt stem cells properties and to maintain 
their stem cell activity144. Id1 gene, that encodes a protein that plays a key role in the self-
renewal of stem cells145, is also upregulated in high-red epithelial iDTR+ cells. This gene is  a 
target of the BMP pathway146 and is reported to be able to maintain the self-renewal and 
pluripotency properties of embryonic stem cells in the absence of BMP145. To note that BMP 
was proposed to be a target of Snai2, since the overexpression of this gene cause the 
downregulation of BMP147.  
 These results point to the downregulation of BMP caused by the overexpression of 
Snai2 and, together with the high expression levels of Wnt genes, they evidence the high 
proliferative profile of this high-red cell population. 
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 Results also show a significant statistical difference of Kcnq1 expression on iDTR+ 
cells. Kcnq1 gene encodes for the pore-forming subunit of a voltage-gated potassium channel, 
enabling a K+ current after electrical depolarization of the cell membrane. Together with Kcne3, 
they form a channel complex known to mediate the cAMP-activated basolateral K+ current, 
essential for luminal Cl- secretion148. Due to this, both genes play a critical role in ion 
homeostasis149. In acidic media, DT forms ion-conducting channels across the plasma 
membrane, conducting to a loss of cell potassium and the entrance of sodium and protons, 
which leads to a consequent rapid decrease of the membrane potential150. Given this, the 
upregulation of Kcnq1 in DT-sensitive cells might indicate that the cells are trying to reverse 
the loss of potassium by creating more K+ channels in order to increase the potassium uptake. 
Also, although both genes co-localize in the basolateral membranes of crypt cells in small 
intestine and colon, their expression levels differ – Kcnq1 is prominently expressed in both of 
the organs, while Kcne3 is expressed in lower levels in the small intestine151 –, which might 
explain the low expression of Kcne3. 
 TPB is a key component of the transcription initiation machinery in eukaryotes, 
being involved in transcription by RNA polymerases I, II and III152. The overexpression of this 
gene increases the transcription from TATA-containing promoter153, indicating that high-red 
iDTR+ cells are expressing more genes, probably essential to maintain the homeostasis given 
their progenitors were under the effect of DT. 
 
 Non-red epithelial cells were also analyzed for the panel of genes mentioned 
above (Figures 4.34 and 4.35), in order to evaluate how the neighboring cells would respond 
to the ablation of the Id2+ cells. 
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Figure 4. 34. Gene expression analysis of Id2 and PUMA in non-red intestinal epithelial cells collected at 
E13.5. Results are shown as mean ± SEM, with N=3. Statistical significance was evaluated with Student's t test. 
*** corresponds to p<0.0001. 
 
 When compared to figure 4.32, results portrayed in the figure above show that the Id2 
expression levels are the same both in non-red and high-red epithelial cells. Regarding PUMA, 
this gene is about 10x less expressed in non-red epithelial iDTR+ cells than in high-red epithelial 
cells in the same condition. This could be due to the fact that homologous recombination was 
quite efficient and gave origin mostly to triple positive cells (Id2+iDTR+dsRed+) and thus there 
are less non-red Id2+iDTR+ cells sensitive do the toxin’s action and, as a consequence, less 
PUMA expression detected. 
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Figure 4. 35. Gene expression analysis of (A) Lgr5, Ascl2, Wnt11, Wtn6, Sfrp5, Rspo1, Snai2, Smoc2, (B) Id1, 
Id3, Kcnq1, TBP, Kcne3, St8sia3, Slc2a3, OneCut and Rspo3 in non-red intestinal epithelial cells collected at 
E13.5. Results are shown as mean ± SEM, with N=3. Statistical significance was evaluated with Student's t test. * 
corresponds to p<0.1 and *** to p<0.0001.  
 
 When comparing the gene expression levels between the epithelial red cells (Figure 
4.33) with the non-red (Figure 4.35), the latter show a different genetic profile. In the non-red 
epithelial cells, even though the expression of Ascl2, Wnt11, Wnt6, Rspo1 and Smoc2 (Figure 
4.35 A) is statistically different between both conditions (iDTR- and iDTR+) – similarly to the 
results shown previously for high-red epithelial intestinal cells –, their expression levels are 
much lower. Only Rspo1 shows an increase in the expression levels, of about 2 times. 
Besides TBP, Slc2a3 expression level is also upregulated and statistically different 
between both conditions – iDTR- and iDTR+ – in non-red epithelial cells (Figure 4.35 B). Also 
known as Glut3, Slc2a3 encodes a protein that belongs to a family of integral proteins and plays 
a role in the transport of monosaccharides and other small carbon compounds across eukaryotic 
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cell’s membranes154.  When undergoing differentiation, the glycolytic flux in embryonic stem 
cells increases dramatically155 and it is known that metabolic pathways might affect both 
homeostasis and quiescence156, so this gene upregulation might be related to the glucose 
metabolism. 
 Taken together, these results  also point to a proliferative character in this population, 
probably to compensate molecular signals that, in normal conditions, should be sent by the Id2+ 
cell population. 
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5. CONCLUSIONS 
The work here presented allowed to gain some insight about the overall efficiency of the 
DT-mediated cell ablation system in mouse embryos, since this methodology is mainly 
described in adult organisms.   
This study aimed to establish a DT-mediated conditional ablation system within the 
embryonic small intestine in mouse cells expressing Id2. This gene, an inhibitor of DNA 
binding and differentiation, is known to play a role in several biological processes and is also 
involved in the lineage specific differentiation of intestinal cells. 
The results presented in this report showed that the DT-mediated ablation system 
implemented triggered the specific apoptosis of the Id2+ cells upon treatment with the toxin, 
since they are the only ones that express the DT receptor at their surface, thus being sensitive 
to the toxin’s action. The apoptosis of Id2+ cells was confirmed by immunostaining and 
histological analysis. Complementary analysis on this cell population performed by FACS, in 
a mouse strain where Id2+ cells present red fluorescence, showed that upon treatment of the 
iDTR+ cells with DT there is a reduction on the red Id2+ cells. Also, FACS analysis on iDTR+ 
mouse embryo epithelial cells suggest a correlation between Id2+ and Lgr5+ cells. The results 
showed that embryos expressing the DT receptor had a decrease of Lgr5+ cells. 
The genetic profile of the isolated high-red and non-red Id2+ cells of iDTR- and iDTR+ 
mouse embryos were evaluated, showing a partial ablation of Id2 in iDTR+ mouse embryos. 
Further analysis by qPCR showed an upregulation in genes involved in cell proliferation – such 
as Wnt6, Wnt11 and their agonists Rspo1 and Rspo3 –, together with genes responsible for stem 
cell properties, as Smoc2 and Snai2. In non-red cells, the same genes were upregulated, but at 
lower levels, suggesting a proliferative response in this population upon the ablation of Id2+ 
cells. 
  
With this study is was possible to conclude that cell ablation mediated by DT is a good 
technique to study the role of the Id2+ cell population in the development of the mouse small 
intestine. Nevertheless, further optimization is needed, namely TAM and DT administration 
and dissection time points, to ensure that the time of dissection is near the time when the Id2+ 
cells start to die. Also, more crossings to obtain Id2CredsRed+/+Lgr5GFPiDTR progeny should be 
done, in order to have a bigger population, and ensure that the results are indeed representative. 
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6. FUTURE PERSPECTIVES 
Even though the data present in this report is indicative of efficiency of the DT-mediated 
ablation system, further optimization is needed and there are some aspects that need to be taken 
in consideration. 
This system depends on blood circulation and on the presence of biological barriers, such 
as the placenta and the blood-brain barrier, and DT is only reported to cross the blood-brain 
barrier in adult mice104. Even though the work developed showed that the DT is able to take 
action in embryos, one of the future approaches could be the evaluation of this system in the 
absence of the potential limiting factors described, using a 3D cell culture technology, derived 
from epithelial embryonic cells collected from embryos, in which the resulting organoids would 
present the structural and functional main properties of the embryonic small intestine157. 
Also, because of the high toxicity of the fragment A of DT, one strategies to minimize 
potential risks to the embryos would be to repeat these experiments with the Id2CreDTA mice 
strain. Instead of having the DT receptor being expressed at the target cells – which will only 
be ablated upon DT treatment –, this stain harbors the gene that encodes for DT-A and, as a 
consequence, only the target cells will synthetize the DT subunit and die. Compared with the 
system used in this work, the DT-A ablation system requires only treatment with TAM in order 
to induce the homologous recombination, and thus it would be a good approach to eliminate 
the time points problems discussed here, allowing a better comprehension of the system. 
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gastrointestinal tract. Pflügers Arch.  Eur. J. Physiol. 2001;442(6):896-902. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/11680623. Accessed September 5, 2016. 
152.  Akhtar W, Veenstra GJC. TBP-related factors: a paradigm of diversity in transcription 
initiation. Cell Biosci. 2011;1(1):23. doi:10.1186/2045-3701-1-23. 
153.  Müller F, Demény MA, Tora L. New problems in RNA polymerase II transcription initiation: 
Matching the diversity of core promoters with a variety of promoter recognition factors. J. Biol. 
Chem. 2007;282(20):14685-14689. doi:10.1074/jbc.R700012200. 
154.  Mueckler M, Thorens B. The SLC2 (GLUT) Family of Membrane Transporters. Mol Asp. Med. 
2013;34(0):121-138. doi:10.1126/scisignal.2001449.Engineering. 
155.  Shyh-Chang N, Daley GQ, Cantley LC. Stem cell metabolism in tissue development and aging. 
Development 2013;140(12):2535-2547. doi:10.1242/dev.091777. 
156.  Ito K, Suda T. Metabolic requirements for the maintenance of self-renewing stem cells. Nat. 
Rev. Mol. Cell Biol. 2014;15(4):243-56. doi:10.1038/nrm3772. 
157.  Clevers H. Modeling Development and Disease with Organoids. Cell 2016;165(7):1586-1597. 
doi:10.1016/j.cell.2016.05.082. 
158.  Sherwood RI, Maehr R, Mazzoni EO, Melton DA. Wnt signaling specifies and patterns 
intestinal endoderm. Mech. Dev. 2011;128(7-10):387-400. doi:10.1016/j.mod.2011.07.005. 
Annexes 
93 
 
ANNEXES 
 
Annex 1: Construction of Id2CreiDTR mouse strain 
 
 
 
 
Annex 2: Anterior and posterior portions of the embryonic small intestine 
Image adapted from Sherwood et al. (2011)158. 
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Annex 3: Construction of Id2CredsRed+/- iDTR 
 
 
 
 
